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PREFACE
Magnetic resonance imaging is widely used as a diagnostic tool in clinical settings. Being
non-invasive and non-ionizing makes it an ideal method to image human subjects in both crosssectional and longitudinal studies. In the past decade, susceptibility weighted imaging (SWI) has
received a great deal of attention in both the research and clinical realms. Due to its new source
of contrast compared to conventional MRI, SWI offers new directions in studying the brain and
its vasculature as well as imaging magnetic material (such as iron). Imaging iron is important
because it is thought to be associated with normal aging and some neurodegenerative disease.
For example, in multiple sclerosis (MS), a complex autoimmune neurodegenerative disease, iron
involvement has been reported in patients both in vivo and post mortem. This iron deposition is
believed to be not only associated with the inflammatory process in MS but also with vascular
abnormalities in the brain and neck.
In this work, we will first validate the ability of SWI to create contrast based on local iron
content and we will use this technique to evaluate iron content in MS patients compared to
normal (healthy) subjects. We will present a new means to extract iron content in large areas,
which eliminates the effect of averaging (previously used) on data assessment. Finally, in order
to study the relation between increased iron content, lesion load and the new theory of vascular
involvement in MS (mentioned above), we will introduce the possibility of developing a vascular
animal model of MS, by emphasizing the similarities and differences in the human and swine
venous drainage system and presenting some preliminary data toward that direction.
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Chapter One
INTRODUCTION
1.1. Background and Project Motivation
Assessing normal human physiological processes and their pathology in vivo became
possible with the advent of medical imaging techniques. Magnetic resonance imaging (MRI), in
particular, is the technique of choice especially in longitudinal studies, since it is a non-invasive
and non-ionizing imaging modality (and therefore safe) (Haacke et al. 1999). It has been shown
to be sensitive and specific in imaging the human anatomy and function due to its high resolution
(which is currently provided at a millimeter level). In most cases, human scanners use proton
imaging. In this case, the source of signal for human MR images comes from the proton
molecules in the body. Historically, contrast has been based on the spin density and relaxation
properties of each tissue although today there are many other tissue properties that can now be
imaged including tissue susceptibility

(Haacke et al. 2009). This latter property makes it

possible to image iron.
Iron, is a paramagnetic molecule, and is known to be the most abundant metal in the brain
(Haacke et al., 2007). Its role in the biochemistry of the human body has made it an interesting
substance for researchers to investigate including but not limited to its distribution, accumulation
over time, and its abnormal deposition in many neurodegenerative diseases such as multiple
sclerosis (Hare et al. 2013).
Multiple sclerosis (MS) has long been defined as an inflammatory demyelinating
autoimmune disease of the central nervous system (CNS) (Noseworthy et al., 2000b). What
initiates the disease and the sequence of events underlying the development of MS is not yet well
understood (Noseworthy et al., 2000b). However, technological progress has shed some
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important insights on many of the factors involved in the pathology of this complex disease. The
pathological landmarks of MS (structural and functional) are characterized by areas of
demyelinated plaques mostly in white matter (WM) and altered global as well as local perfusion
(Filippi et al., 1998; Haacke et al., 2009a). This is also observed to a lesser degree, in the cortical
regions, specifically near the gray matter (GM)/WM boundary and in gray matter as well
(Haacke et al., 2009a; Nelson et al., 2007). Determining whether the starting point is in the GM
or WM remains unclear (Allen et al., 2001; Neema et al., 2009; Nelson et al., 2007). Finally iron
accumulation has been reported predominantly in the deep gray matter (basal ganglia and
midbrain) (Adams, 1988; Eissa et al., 2009; Filippi and Rocca, 2009; Haacke et al., 2009a; Varga
et al., 2009).
Brain iron accumulation in MS has been shown histologically in the past (Craelius et al.,
1982; Levine and Chakrabarty, 2004). Iron deposition was seen in and around white matter
lesions (mostly perivenular), in the deep gray matter area (basal ganglia and midbrain) and in an
antegrade fashion along the venous drainage system (such as thalamostriate system) (Haacke et
al. 2010). This has been hypothetically linked to a new theory known as chronic cerebrospinal
venous insufficiency. This study showed that MS patients tend to have extracranial venous
abnormalities such as obstruction of the internal jugular veins in the neck and the azygos vein
along the thoracic vertebral column (Zamboni et al., 2009), (Haacke et al., 2012c). These
abnormalities lead to alteration in the blood drainage from the brain and produce a hemodynamic
effect which is thought to be related to the clinical outcomes of MS. These outcomes have
increased the research community’s interest in assessing iron and flow involvement in MS which
might provide clues to the link between white matter lesions, iron content and flow
abnormalities.
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The motivation for studying iron and its relation with vascular abnormalities in this thesis
was therefore based on all the observations mentioned above. Specifically, I will address: 1) the
ability of susceptibility weighted imaging in resolving the main structures and substructures of
the midbrain which are thought to be affected in neurodegenerative diseases; 2) measuring iron
content in MS patients with age matched healthy normal controls in vivo as a means to develop a
new imaging biomarker for MS; and 3) the possibility of developing a new MS vascular animal
model to study the link between vascular abnormalities, iron deposition and sclerotic lesions.
The remaining chapters in this thesis are arranged as follows. Chapter two gives a
detailed overview on iron in the body and the brain, its function under normal conditions and its
involvement in many diseases (“when it behaves badly”). Chapter three presents the basics of the
MR gradient echo concept and how it is used to generate susceptibility weighted magnitude and
phase images (which will be used to visualize different structures of the brain and assess their
iron content in MS patients and healthy controls). Chapter four uses high contrast SWI data to
differentiate between basic mesecephalic structures including the red nucleus, the substantia
nigra and the crus cerebri (paper published in AJNR). Chapter five describes the basics of what
is known about MS and its clinical manifestation including white matter and gray matter lesions
as well as iron deposition. Chapter six tests the specificity of SWI compared to X-Ray
fluorescence in imaging iron content in MS cadaver brains (paper published in AIP). In chapter
seven, iron in the basal ganglia and the midbrain is assessed using SWI and compared between
healthy controls and MS patients (published in AJNR). Chapter eight presents part of our work
on developing a new MS vascular animal model where we assess the similarities and differences
in the venous drainage system between pigs and humans (published in JMRI). Finally, chapter
nine discusses conclusions and future directions.
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1.2. Project Aims:
In this dissertation, MRI methods will be used to visualize and evaluate iron content in
the basal ganglia and midbrain, to assess whether MS patients (in vivo and ex vivo) suffer from
increased iron content in the brain and to evaluate the similarities between the cerebral
vasculature of the swine and the human, as a means to develop a new vascular model for
neurodegenerative diseases such as MS. The specific aims and hypotheses of this proposal are:
Specific aim 1: To collect high-contrast SWI data to differentiate between and within the basic
mesencephalic structures; namely, the red nucleus, substantia nigra and crus cerebri.
Hypothesis: Using SWI, it is possible to create better anatomical images of the mesencephalon,
with improved contrast compared to conventional T1 or T2-weighted sequences.
Specific aim 2: To visualize and validate iron deposition using rapid scanning X‐Ray
Fluorescence (RS‐XRF) and SWI in two MS cadaver brains.
Hypothesis: XRF will show similar contrast as SWI and reveal perivascular iron deposition in
MS lesions.
Specific aim 3: To evaluate iron content in the basal ganglia and midbrain of MS patients using
SWI and to compare the results to a previously established baseline of normal iron content as a
function of age.
Hypothesis: MS patients have much higher iron in the midbrain and basal ganglia than age
matched normal controls.
Specific aim 4: To investigate the similarities and differences between the human and pig
(swine) cerebral vasculature using MR venography and angiography.
Hypothesis: The swine brain’s vasculature and flow will be similar to that in humans, presenting
the swine as a good large animal model to study the vascular aspects of MS.
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Chapter Two
IRON IN THE BRAIN
Chapter Overview
In this chapter, we explore the most abundant metal in the brain, iron, and we emphasize
its importance in the body and in the brain. We describe its different types and their role based
on their composition. The iron distribution in the brain and its relation with age are discussed.
Pathological examples are given showing the potential role of abnormal iron level in
neurological diseases. Finally, common magnetic resonance imaging methods that have been
used to image and quantify iron in vivo are highlighted.

Introduction
Understanding the pathological role of iron in the brain has been one of the major focuses
of neurological research for decades. Iron has been associated with the outcome and potential
pathogenesis of many neurodegenerative diseases such as Friedrich’s ataxia, Huntington’s
disease, multiple sclerosis, Parkinson’s disease and other iron related genetic diseases (Bartzokis
et al., 1994; Beard et al., 1993; Connor and Menzies, 1995; Connor et al., 1995; Gelman et al.,
1999; Goodman, 1953; Haacke et al., 2005; Hallgren and Sourander, 1958; Koeppen, 1995; Ogg
and Steen, 1998; Ordidge et al., 1994; Pfefferbaum et al., 2009; Quintana et al., 2006; Schenck
and Zimmerman, 2004; Schenker et al., 1993; Siemonsen et al., 2008; Stankiewicz et al., 2007;
Vymazal et al., 1996; Xu et al., 2008; Zaleski, 1886). The importance of iron homeostasis in the
brain is due to its major role in several biological processes such as normal brain metabolism,
cell division, mitochondrial function, oxygen transport, neurotransmitter synthesis, electron
transfer and myelin production (Quintana et al., 2006; Stankiewicz et al., 2007). However, it is
believed that any deviation from homeostasis of iron can cause neurotoxicity leading to a
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spectrum of neuropathological outcomes (Quintana et al., 2006; Schenck and Zimmerman, 2004;
Stankiewicz et al., 2007). To avoid this issue, living organisms have developed systems to store
this excess of iron and work as a buffer against iron overload and deficiency (Ropele et al.,
2011).
The normal adult human body contains 3 to 5g of iron. Iron is categorized as being either
heme-iron (found in hemoglobin - in this state, iron plays a major role in oxygen transport) or
non-heme iron. Non-heme iron can appear in low molecular weight complexes, metalloproteins
(such as transferrin), ionic iron, as well as ferritin and hemosiderin (molecules that are
responsible for iron storage) (Haacke et al., 2005).

Figure 2.1: The heme cofactor of the protein hemoglobin (Bizzi et al., 1990)

Heme-iron (figure 2.1) contains two thirds of the total iron in the body while the other
third appears as non heme-iron mostly in the form of ferritin (Hallgren and Sourander, 1958).
Iron appears to preferentially be in the form of ferric (Fe3+) more than in ferrous (Fe2+) iron.
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2.1 Iron types
Ferritin (molecular weight = 474kg/mol) is mainly a soluble iron storage protein and
barely involved in metabolic activities. It plays a role in maintaining homeostatic levels of iron in
the human body. This protein can store up to 4500 iron atoms (figure 2.2). It is composed of
twenty four subunits consisting of heavy (H-ferritin) and light (L-Ferritin) subunits. Different
combinations of H and L chains define the physiochemical properties of each ferritin protein. Hrich ferritin proteins are more efficient in iron sequestration (where iron uptake is dominant,
given that H-chains take up and release iron more rapidly than L-chains) (Beard et al., 1993).
Heretofore, H- ferritin is the responsive protein that acts in the early stages of iron accumulation
whereas L-subunit ferritin plays a role as storage protein in later stages making L-rich ferritin the
proteins of choice for iron storage (Haacke et al., 2005). H-chains are usually found in neurons
(oligodendrocytic cells) and L-chains are found in glial cells (macrophages and microglia)
(Connor and Menzies, 1995; Connor et al., 1995). Moreover, H-ferritin is dominant in organs
that require iron detoxification such as the heart and the brain since its physiological task is to
protect cells from the redox active Fe2+. That is why it accumulates almost 90% of non-heme

iron
Figure 2.2: Ferritin molecules store thousands of iron atoms within their mineral core. (cdc.gov)

8

iron in order to provide a cellular protection through its H-subunit. On the other hand, L-subunits
are responsible for the facilitation of mineralization (Connor and Menzies, 1995; Connor et al.,
1995). These ferritin proteins increase with age except in the substantia nigra, and the ratio H/L
decreases with age (Connor and Menzies, 1995; Connor et al., 1995).
Hemosiderin, the second iron storage protein, is insoluble and is considered to be a
degradation product of ferritin. Studies have showed that the majority of brain iron in diseased
brains is in the form of hemosiderin aggregates rather than isolated ferritin molecules (Schenck
and Zimmerman, 2004). For instance, when an extravasation of blood takes place, the brain
converts the heme-iron to hemosiderin. This is important when studying subarachnoid
hemorrhage (Imaizumi et al., 2003), stroke (Kleinig, 2013), cerebral amyloid angiopathy in
dementia (Chao et al., 2006) and in traumatic brain injury (Benson et al., 2012).
Transferrin (molecular weight = 79.6kg/mol) – another non-heme iron protein – plays a
role in delivering the iron to the whole body and the brain across the blood brain barrier (from
the blood to the brain tissue) via specific receptors located in the microvasculature (Haacke et al.,
2005). The transferrin chain (which is composed of two carbohydrate groups and amino acids)
can only bind two iron atoms (making transferrin undetectable using magnetic resonance
imaging). Transferrin, transferrin mRNA and transferrin receptor expression in the normal brain
are related to oligodendrocytes and myelin formation whereas ferritin is a marker for normal and
activated microglia in the CNS.

2.2 Iron distribution in the brain
Iron in the brain is heterogeneously distributed, specifically in the white matter, gray
matter, and the cerebral cortex (Haacke et al., 2005). Enhancing Perl's staining for visualizing

9

iron in tissue using diaminobenzidine tetrahydrochlride has revealed more histochemical details
showing iron in many cell types of the CNS such as neurons microglia, oligodendroglia,
astrocytes and in some myelin sheaths (Koeppen, 1995). Iron and ferritin have been
histologically reported to be equally distributed in GM and WM, while transferrin seemed to be
more abundant in WM compared to GM (Connor et al., 1992). In the deep gray matter, the
structures were found to accumulate ferritin at different rates as a function of age (see next
section). Total iron values have been found to be highest in the globus pallidus (GP), followed by
the putamen (PUT), caudate nucleus (CN), thalamus, cortical gray matter and cortical white
matter as well as in the dentate nucleus (Koeppen, 1995). The distribution of non heme iron is
found in the motor cortex with highest concentration followed by, decreasingly, the occipital,
sensory, parietal, prefrontal and temporal cortex (Hallgren and Sourander, 1958). Xu et al.
showed that the left hemisphere has more iron than the right hemisphere specifically in the PUT,
GP, substantia nigra (SN), thalamus (THA) and the frontal WM. However, no significant
difference was found while comparing the results according to gender (Xu et al., 2008).

2.3 Iron and Age
Another point of interest in studying iron in the brain is the understanding of its
dependability on age. Iron levels have been shown to be low in newborn brain and start
increasing rapidly until the age of 20 to 30 years, where it reaches stable levels (Goodman, 1953;
Hallgren and Sourander, 1958; Xu et al., 2008; Zivadinov et al., 2010). Iron uptake into the brain
reaches its maximum during rapid brain growth which concurs the peak of myelinogenesis
(Beard et al., 1993), and continues throughout life. However, some controversies have been
reported based on the assessments of specific regions and using different methods (Haacke et al.,
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2010c). In the literature, iron deposition as a function of age has been reported for many
structures individually (basal ganglia, thalamus and midbrain). For instance, the PUT, pulvinar
thalamus (PT) and red nucleus (RN) showed increased iron deposition till the 5th decade and 6th
decade, with the highest rate in the first two decades (Hallgren and Sourander, 1958; Zivadinov
et al., 2010). Same effect was seen in the CN but at a faster rate in the 4th decade. The GP on the
other hand showed an increase till the 3rd decade to reach a plateau at the age of 30. There was
no agreement between studies on how does iron behave in the thalamus with age (Zivadinov et
al., 2010). One study reported no change as a function of age (Xu et al., 2008); another showed
increase linearly with age (Haacke et al., 2010c), while others showed a similar behavior as the
GP (Hallgren and Sourander, 1958). Finally, many studies agreed that iron the SN increases
rapidly in the first 2 decades of age and reaches a constant value throughout life (Haacke et al.,
2010c). Striatal and brain stem structures have higher iron concentrations in older people
whereas cortical white matter and thalamus have higher iron concentrations in the younger
people (Pfefferbaum et al., 2009). This effect has been seen in the RN and SN as well. As can be
seen from the previous discussion, levels of non-heme iron are not uniform spatially or
temporally.
In the next section, we will go over some pathologies where iron abnormalities seem to
contribute to the etiology of these diseases.

2.4 Iron and Neurodegenerative Disease
Iron misregulation in the body and specifically in the brain, has long been associated with
neurodegenerative disease (Sullivan, 2004). The mechanisms of damage linked to iron are
differently described based on each disease and yet these mechanisms are still debatable (Hare et
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al., 2013). Some studies reported that oxidative stress might be the triggering factor, while others
stated that a pathological process leads to iron accumulation and creates a pathophysiological
loop involving iron (Hammond et al., 2008). Some of these processes have been identified as
cellular, immunological and others as vascular (Haacke et al., 2012b). The complexity of the iron
uptake and regulation on a cellular level makes this mechanism susceptible, leading to disruption
of its normal function and to cellular degradation and pathogenic pathways.
To emphasize the complexity of this mechanism, the following paragraph will briefly go
over iron circulation and brain uptake. A more detailed description of these mechanisms can be
found in the review by Hare el al. (Hare et al., 2013).
Transferrin is the major iron transporter in the body. It can hold two iron molecules each.
At a given time, and under normal conditions, only 30% of transferrin proteins are occupied.
Once in the blood and occupied, Fe2Tf cannot cross the blood brain barrier due to the
hydrophobic barricade. To cross the blood brain barrier (BBB), Tf binds to Tf receptors, which
pass through the brain capillary endothelial cells, as an endocytotic mechanism. Another way of
iron import to the cell is through low molecular weight complexes. Export of iron is regulated by
ferroportin, which is manipulated by the expression of tau and ceruloplasmin, controlling the
available iron in the so-called labile iron pool. The latter is regulated by cellular metal sensing
and iron binding protein expression (such as ferritin), based on the status of iron and the demand
by the cell. Controlling iron homeostasis doesn’t only happen with iron regulation, but can also
be manipulated via regulation of iron associated proteins. For instance, Tf export from the cell is
done through divalent metal transporter-1 (DMT-1). The proper function of DMT-1 will play a
role in the availability of apo-Tf which in charge of binding to iron and deliver them under iron
overload or depletion conditions (Hare et al., 2013). This shows the number of factors involved
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in iron regulation and therefore, it can be expected that disturbance of iron metabolism can occur
at several levels: iron uptake and release, storage, intracellular metabolism and regulation
(Stankiewicz et al., 2007).
When any of these iron levels are disturbed, neurochemical effects go into play leading to
perturbation of neurotransmitter signaling and variation in energy and myelin production (Hare
et al., 2013). These changes lead to a spectrum of pathogenic pathways based on their role in
maintaining a healthy body. One would expect that changes in the neurotransmitter levels will
affect motor skills, language, mood and attention. One well-known disorder that manifests in
hyperactivity, inattention and impulsiveness is attention deficit hyperactivity disorder (ADHD).
It is believed that the involvement of iron in dopamine neurotransmission might be play a role in
ADHD if brain iron deficiency occurs (Konofal et al., 2004). In addition, the brain is always in
high energy demand. Given that mitochondrial enzymes do frequently utilize iron, iron depletion
might impair their function leading to a decrease in energy production and increase in oxidative
stress (Walter et al., 2002). On the other hand, when production of myelin is in jeopardy, one
would expect a series of neurological symptoms due to the decrease integrity of the neurons.
Although this is still an underexplored subject, iron accumulation and demyelination accompany
many neurodegenerative diseases, including Parkinson’s disease, Huntington’s Disease and
Multiple Sclerosis (Quintana, 2007; Stankiewicz et al., 2007).

In the past, abnormal iron

deposition assessment was only possible postmortem; however, with recent advances in imaging
techniques, it became possible to not only visualize but also monitor these changes in vivo. These
techniques are discussed in the next section.
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2.5 Iron as seen with MRI
The ability of MRI to create an image of the human body lies behind the fact that its
signal originates from the protons of the water molecules. In addition, the contrast generated is
based on the tissue properties of each structure whether via total water content, relaxation times
or other imaging characteristics. The presence of metals in sufficient amount will alter the
magnetic properties of the tissue and generate a contrast change (via relaxivity and susceptibility
effects), making it possible to visualize and quantify them in vivo. However, if other metals also
exist in the brain but in small concentrations (such as copper, zinc, etc…), their presence will not
affect the quantification of iron given that their effects on the local magnetic field is negligible.
There has been considerable interest in normal brain iron quantification as well as in
neurodegenerative diseases in order to understand their pathogenesis, monitor their progress and
establish neuro-protective treatments (Hagemeier et al., 2013; Langkammer et al., 2013; Lim et
al., 2013; Muhoberac and Vidal, 2013; Yang et al., 2013). Developing and improving MRI has
been an important task for decades, trying to establish a correlation between the observed signal
and iron concentration. Ferritin and hemosiderin are the two major molecules that are considered
to be the only forms of non-heme iron present in sufficient quantities to affect MR contrast in the
brain (Haacke et al., 2005). On the other hand, iron related proteins such as transferrin,
transferrin receptor and the ferritin receptor protein are almost undetectable using MR due to
their low concentrations.
Many MR imaging techniques have been used to measure iron in vivo due to the effect of
iron on signal intensity. As described below, each technique has its advantages as well as its
drawbacks. While some MRI sequences did not achieve a strong correlation with iron (such as
T2, for example), many others showed promising results for iron evaluation such as T2′ and T2*
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quantification (Gelman et al., 1999; Ordidge et al., 1994) as well as Field-Dependent Relaxation
Rate Increase (FDRI) (Bartzokis et al., 1993), magnetic field correlation (MFC) (Jensen et al.,
2009), and susceptibility weighted imaging (SWI) (Haacke et al., 2010c).

T2, T2* and T2' weighted imaging:
Relaxation rates (R2, R2* and R2') are reported to increase with an increase in the
concentration of paramagnetic material (Haacke et al., 2005). Therefore, in the presence of iron,
darkening or hypointensities are visualized in structures with high iron deposition. In addition,
T2* and T2 both decrease with increasing magnetic field. The drawback of R2 (also R2* given
that R2* = R2 + R2'), is its sensitivity to not only iron but also water content, which makes R2 an
imprecise method to evaluate iron when diseased tissue is imaged. For instance, if a lesion with
edema is imaged, it has high water content, which will lead to a decrease in R2, and therefore,
iron content will be underestimated. Therefore, R2' has become a better, more accurate approach
to image iron, as it takes out the water fraction effect and makes it possible to evaluate the signal
change due to local susceptibility variations seen in the presence of iron. These measures have
been reported to better correlate with iron concentration. Although R2 showed more sensitivity
to GM/WM differentiation then R2′, R2 was not able to present specificity for iron (Ordidge et
al., 1994). On the other hand, R2′ showed a good correlation with iron load (Schenker et al.,
1993). In another study, T2′ and T2* decreased in GM but increased in WM in the aging brain
(Siemonsen et al., 2008). More detailed discussion of these concepts, as used in this thesis, will
appear in chapter 3.
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T1 weighted imaging:
T1 weighted imaging has also been used as a means to investigate iron in the brain. Iron
can create a dipolar relaxation mechanism, during which water protons sense magnetic field
fluctuation created by ferritin and water diffusion in its vicinity. This dipolar relaxation has an
effect on the longitudinal magnetization and, theretofore, a signal increase is seen on T1
weighted images. Based on this mechanism, T1WI can correlate iron concentrations in the brain
as seen in postmortem brains (Ogg and Steen, 1998; Vymazal et al., 1996) and shows a good
linear dependency on iron, but with a lower effect compared to T2. In addition, T1 effect is field
dependent and falls off at higher field while T2 is field independent (Vymazal et al., 1996).

Phase Imaging:
Phase is proportional to local magnetic field changes. The latter is proportional to the
local magnetic susceptibility which is a direct measure of local iron content. Phase has been
shown to be sensitive to iron and shows a strong correlation as a function of age (Haacke et al.,
2010c). More recently, phase has been used to generate a quantitative susceptibility map (Zheng
et al., 2013), which also correlates well with iron deposition. This approach takes away the
dependability of phase on spatial susceptibility distribution and orientation and avoiding many of
the problems currently faced with phase alone (Schafer et al., 2009). The ability of phase to
image iron will be described in more detail in the next chapter.
Several other techniques have been used to image iron in vivo but will not be discussed in
details here. Of these methods, FDRI (which evaluates the differences in R2 at two different field
strength), was used by Bartzokis et al. to image iron content and has shown a good agreement
with iron concentration (ferritin specific) in normal aging (Bartzokis et al., 1993); and MFC
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Imaging (Jensen et al., 2009) (which is composed of a series of asymmetric spin echo sequences
giving a T2* like contrast to evaluates microscopic field variations as a means to assess iron
content).
Each of these methods mentioned above has its drawbacks, however, some methods will
always present relative measures (relaxation times and MFC approaches), while others will offer
(when all confounding factors are eliminated) an absolute quantification approach by directly
evaluating and mapping magnetic susceptibilities (such as QSM). It is strongly noted that
although phase and susceptibility effects seen on MR images exhibit a strong contrast between
white matter and gray matter, this contrast is not solely generated by iron; instead, myelin
sheaths which are wrapping the neuronal bundles in the WM are diamagnetic, which decreases
the susceptibility values in the region of interest and underestimates iron contact in these regions
(Liu et al., 2011). This chapter presented an overview on iron and its role in the human body and
brain and discussed some pathological consequences when iron deviates from its normal levels.
We also listed some approaches which are currently in use to evaluate iron content in vivo. In the
next chapter, we will talk in depth about one of these MR methods, phase imaging, acquired
using gradient echo acquisition scheme, and which will then be used to evaluate iron content in
normal controls and MS patients as will be described in chapters 4, 6 and 7.
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Chapter Three
SUSCEPTIBILITY WEIGHTED IMAGING
Chapter overview
In the past decade, susceptibility weighted imaging (SWI) has received a great deal of
attention in both the research and clinical realms (Haacke et al., 2009b; Mittal et al., 2009). Due
to its new source of contrast compared to conventional MRI, SWI presents new directions in
studying the brain and its vasculature as well as other organs in the body, where magnetic
materials (source of contrast) seem to play an important role in normal aging and disease states
of these structures. In this chapter, we will explore the basic concepts of SWI, ranging from basic
physics, image acquisition to post processing and creation of the magnitude, phase and SW
images which will be used in later chapters to image the brain and assess iron content in vivo.
We will emphasize the effect of susceptibility on the MR signal, the gradient echo acquisition
scheme used in SWI, and how phase will be used to generate the SW image contrast.

Introduction
As emphasized in its name, SWI highlights the susceptibility differences between tissues,
presenting a new type of contrast different from what is seen in spin density, T1 and T2 weighted
imaging (Haacke and Reichenbach, 2011). The information that underlies this new contrast
comes from the phase images which prior to the introduction of SWI were disregarded for a long
time in MR applications. As we will see in the next few sections, phase reflects the sources of
magnetic material distribution, albeit often in a non-local fashion. The steps used to create SW
images are shown in figure 3.1 (Haacke and Reichenbach, 2011) , and will be described in detail
throughout this chapter.
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Figure 3.1: Steps involved in creating SW Images

In brief, SW images are acquired based on a 3D, fully flow compensated, high resolution
gradient echo sequence. The 3D high resolution nature of SWI allows for the acquisition of
thinner slices which reduces the signal loss from background field homogeneities (Haacke et al.,
2009b). To make the phase images useful, a special high pass filter is applied to remove
unwanted low spatial frequency undulations and aliasing artifacts. This new filtered phase image
is used to create a phase mask that is then applied onto the magnitude image. The final SW
image combines both magnitude and phase contrast: the former coming from the T2* effects and
the latter reflecting susceptibility effects. The details of these steps will be expanded in the
remaining sections of this chapter.
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3.1 Magnetic Susceptibility
Magnetic susceptibility is defined as the tendency of a substance to become magnetized
when it is placed within an external static magnetic field (Haacke et al., 1999). Once magnetized,
an induced magnetic field (M) is seen inside the object and will lead to perturbation in the
magnetic field outside the object to a different degree based on the object shape, volume,
magnetization and position. The full expression for the magnetic field inside the material, under
the influence of the magnetic field (B0), is given by Equation 3.1:

B = µ0 (H+M)

(3.1)

where B is the resultant magnetic field in Tesla (T), H is the magnetic flux in A/m, M is the bulk
magnetization per unit volume of the substance in A/m, and µ0 is the absolute permeability of
free space (4π x 10-7) with units of Tm/A.
M inside the object and the H field are related through the magnetic susceptibility χ:

M=χH

(3.2)

Therefore, Equation (3.1) can be re-written as:

B=(

) µ0 M

For linear materials with χ << 1, equation (3.3) can be written as:

(3.3)
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M = χB/ µ0

(3.4)

showing the proportionality between the induced magnetization, the main field and the magnetic
susceptibility (Haacke et al., 2009b). Based on the value of χ, the material can be characterized
as paramagnetic (χ > 0), diamagnetic (χ < 0) and ferromagnetic (χ>>1). Ferromagnetic materials
are not reported in biological organisms, however, paramagnetic forms of iron and diamagnetic
forms of calcium are both found in humans (Haacke and Reichenbach, 2011).
Based on what we discussed earlier, any object placed within an external magnetic ﬁeld
gets magnetized (based on its susceptibility) and usually changes the induced magnetic ﬁeld
within and outside the object (Haacke et al., 1999). These changes have a high dependence on
the object geometry and its orientation with respect to the main magnetic field. These field
changes are easily calculated for objects with structural symmetries like a sphere and a cylinder.
These two geometries are convenient given that blood vessels can be modeled by long cylinders
and sinuses are modeled by spheres. The derived solutions for these structures implicitly explain
what we see on phase images when we look at structures like vessels. Following equation 3.4
and considering that the objects are in vacuum, the field perturbation inside and outside these
objects are summarized in table 3.1. However, when these objects are embedded in an external
medium with some finite susceptibility, χ is replaced by Δχ, in addition to other terms related to
the geometry of the external compartment (Haacke and Reichenbach, 2011).
From the concepts described above, tissues with different susceptibilities will exhibit
spatially varying precession frequencies as manifest through the Larmor frequency that is given
by:

ω = -γ.B

(3.4)
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where γ is the gyromagnetic ratio of the proton, ω is the precession angular frequency and B is
the induced magnetic field seen by the proton. How this signal is acquired will be the topic of
next section.

Table 3.1: Expressions for Field Inside and Outside a Uniform Sphere and an Infinitely Long
Cylinder (Haacke and Reichenbach, 2011).

In this table, a is the radius of the cylinder or the sphere; θ represents the angle that the long axis
of the cylinder makes with B0 or the angle that the position vector r of the point of observation
makes with the main magnetic field B0 for the spherical case; r is the position vector of the point
of observation and Φ is the polar angle subtended by r on the plane perpendicular to the long axis
of the cylinder.

3.2 Gradient Echo Imaging
In the presence of an external magnetic field (B0), the proton spins tend to align in a
parallel and anti-parallel fashion along B0, based on their thermal and magnetic energy. Spin
excess in the direction of the main field leads to a bulk magnetization M (Haacke et al., 1999). In
order to be able to measure an MR signal, M should be tipped away from the main magnetic
field direction. A time varying radiofrequency pulse perpendicular to M, corresponding to the
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precessional frequency of M (known as Larmor frequency – eq. 3.4), is applied to the system.
Once in the transverse plane, the net magnetization starts precessing along B0, creating a varying
flux across the receiving coil and generating an electromotive force (emf). The measured emf is
is referred to as the free induction decay (figure 3.2). This decay is caused by intrinsic
interactions of the spins (dephasing) and field inhomogeneities (Haacke et al., 1999). The latter
was addressed historically by the use of the spin echo. The spin echo sequence used a π-pulse to
invert the phase of these spins and create an echo. However, these sequences take long time,
limiting the ability to rapidly acquire high resolution MR data. With a modern system, where
global field inhomogeneity has become less of a problem, and the availability of dependable time
varying gradients, a more modern concept known as gradient recalled echo (GRE) imaging has
become routinely used in every clinical MR application (Haacke and Reichenbach, 2011). The
advantages of GRE relies on the fact that short echo times are possible eliminating a lot of
artifacts from the T2* signal decay. In addition, the use of high bandwidth decreases the
distortion.
GRE imaging uses large and fast switching gradients to dephase and rephase the MR
signal in order to create an echo or multiple echoes based on the application (Haacke et al.,
2009b). Figure 3.3 represented an example of a 1D gradient echo showing the dephasing, the
rephasing and the echo. In the figure on the left, the gradient is dephasing the spins between t1
and t2. In the figure on the right, the spins are rephased when the polarity of the gradient has
switched, creating an echo at time t = t4 – (t4-t3)/2 (Haacke et al., 1999). When the spins are
refocused in the MR signal, only the dephasing created by the gradients is reversed and not the
phase shifts from the field inhomogeneities, tissue susceptibilities and the chemical shift fields.
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Some of these effects will be dealt with later by the application of special filters (high pass filter:
see section 3.4).

Figure 3.2: a) Free induction decay in the laboratory frame. b) the free induction decay signal in
the rotating frame.

Understanding the effect of imaging parameters on gradient echo sequences is very
important. For instance, in order to collect a 2D or 3D dataset, the diagram shown in figure 3.3
should be repeated many times (Frahm et al., 1986). The repetition time (TR) will now play an
important role in manipulating the available signal. Therefore, it is critical to understand how TR
affects the available magnetization at each repetition time in both the longitudinal and transverse
planes. In the cases were TR is much longer than T2 relaxation, transverse magnetization tend to
vanish prior to the next rf pulse. However, when TR is shorter than T2, transverse magnetization
is still available and needs to be removed prior to the next acquisition. On the other hand,
longitudinal magnetization availability is affected by TR and the flip angle (FA). The right
combination of TR and FA will be required to get the best contrast and signal to noise in the
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image (Haacke and Reichenbach, 2011). To get a better flavor of this concept, we will introduce
the concept of steady state gradient echo imaging.

Figure 3.3: 1D gradient Echo experiment.

The repetition of the rf pulse prior to data collection is needed to reach magnetization
equilibrium. This will depend on the FA used for that case. For large flip angles, the equilibrium
is reached with only few rf pulses compared to several hundred rf pulse with low flip angles
(Frahm et al., 1986; Frahm J, 1986). The equilibrium longitudinal magnetization is given by
equation 3.5:

Mze = M0. (1-e-TR/T1)/(1-cosα.e-TR/T1)

(3.5)

A clear dependence on both FA and TR is seen in equation 3.5. The transverse equilibrium
magnetization based on eq. (3.5) is given by:
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ρm(α) = M﬩ = M0. (1-e-TR/T1)/(1-cosα.e-TR/T1). sinα. e-TE/T2*

(3.6)

Taking the derivative of eq. (3.6), one can show that the maximum signal occurs at the Ernst
angle αE with:
αE = cos-1 (e-TR/T1)

(3.7)

where αE =
when TR<<T1 (Haacke et al., 1999).
Equation 3.6 can tell us a little more about how changing the parameters affect the image
contrast. For instance, at low flip angles, the image becomes dominated by spin density contrast
for TE much smaller than T2*. On the other hand, T1 weighted imaging is achieved when a large
flip angle is selected.

The acquired MR signal is a complex signal which can be represented by a magnitude and phase
(Haacke et al., 2009b):

Sxy(t) = |Sxy(0)| eiφ(r, t)

(3.8)

The MR scanner hardware is used to demodulate the signal into real (Sx(t)) and imaginary (Sy(t))
channels. The final images usually output on the scanner are the magnitude of the complex signal
|Sxy(t)| and the phase image (equal to tan-1 (Sy/Sx)) (Haacke et al., 1999). This phase is dependent
on the position of the spin and the time. Therefore, phase is represented as:
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φ (r, t) = -ω0.t + γ(B(r))t = -γΔBt (with ΔB = gΔχB0)

(3.9)

B(r) shown in eq. (3.9) includes the susceptibility information in addition to field variations due
to chemical shifts and global geometry. As shown in the spherical and cylindrical cases, field
variation can occur not only locally inside the object but also external to the object as well. These
field variations were the main reason why the phase images were usually disregarded in the past.
Finally, adding the phase component to eq. (3.6) yields:

ρ(α) = ρm(α) e-iγΔBTE

(3.10)

Now that we have explained the concept of gradient echo imaging, we will move forward
to a more detailed description of how this imaging approach is applied to acquire SW images.

3.3 Susceptibility Weighted Imaging
SWI is a 3D, fully flow compensated, rf spoiled gradient echo sequence (figure 3.4)
(Haacke and Reichenbach, 2011) . The terminologies mentioned herein will be described one at a
time. 3D sequences are generally used to allow a higher resolution imaging in plane and through
plane (better definition independent of the rf pulse). In some cases, the signal to noise of the
dataset acquired is higher compared to 2D. 3D imaging is achieved by exciting a slab to cover
the area of interest and then the data is spatially resolved in the 3D volume by applying partition,
phase and frequency encoding. In addition, flow is compensated in all three directions (Haacke et
al., 1999). The reason we are interested in applying flow compensation apart from avoiding
motion artifacts is our interest in the phase that results from local susceptibility.
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Figure 3.4: Original sequence diagram for SWI with flow compensation.

For uncompensated sequences, the presence of flow in the vasculature of the brain along the
bipolar dephasing/rephasing gradient direction leads to an additional accumulation of phase to
what was shown in eq. (3.8) (Haacke et al., 1999). A spin moving with a constant velocity v
along the read gradient will have phase of:

φ = γGxvτ2

(3.10)

Therefore, using a first order gradient moment nulling in the read and slice select
direction and applying appropriate velocity compensating gradient waveforms in the phase and
partition encoding gradients will lead to a full flow compensation, by removing all the
accumulated phase from flow at echo time in addition to removing all the pulsatility effects
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caused by variable phases across the cardiac cycle. On the other hand, signal variations caused
by varying inflow, can only be removed by using low flip angles which reduce T1 dependence
on the signal. Given the short TR used in SWI, transverse magnetization is usually still available
prior to the second rf pulse. Therefore, gradient and rf spoiling methods are applied in every
repetition to ensure no remnant magnetization is found in the transverse plane (Haacke and
Reichenbach, 2011). The former is achieved by including variable gradients between rf pulses
(after data acquisition) while the latter is achieved by varying the phase of the rf pulse (usually
117 degrees) as a function of the rf number. Resultant magnitude and phase images are shown in
figure 3.5 below.

Figure 3.5: SWI magnitude and phase images acquired at 4T with a TR/TE/FA of 35/25/15.

3.4 SWI filtered Phase Images (Homodyne High Pass filter)
The images in figure 3.5 show beautiful contrast between different structures of the brain,
however, the phase image on the right is confounded by unwanted artifacts resulting from low
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spatial frequency components of the background field (ΔBglobal geometry + ΔBmain field) (Haacke et
al., 2009b). To make this image more useful, a high pass filter is applied. This high pass filter is
created by using an n x n low pass filter divided into the original phase image. This is
mathematically represented by equation 3.11 below:

ρ' (r) = ρ (r)/ ρn (r)

(3.11)

where ρn (r) represents the truncated n x n complex image.
This filter size can vary from as little as 16 x 16 for a 512 x 512 original image, to 96 x
96. However, it should be noted that choosing too large a high filter size can remove useful
information from large structures, decreasing their contrast and adding an error in quantification
studies based on phase images. Studies have shown that a 64x64 filter size does a good job
removing low spatial frequency components while maintaining useful information in the phase
data (Haacke et al., 2007). An example showing the effect of different filter size is shown in
figure 3.6.
As mentioned earlier, this approach presents in a single image the susceptibility contrast
from the phase images and the signal intensity contrast (based on T2*) from the magnitude
images. This is accomplished by creating a binary mask from the phase images, which
suppresses phase of certain values.
For instance, when the negative phase is of interest, the binary mask sets all the phase
values at point x, which are positive to 1, and emphasizes the negative values (Haacke et al.,
2009b). This negative mask is given mathematically in equation (3.12):
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f(x) = [π + φ (x)]/π
1

for –π< φ (x) <+π

(3.12)

otherwise;

Figure 3.6: Applying a high pass filter of different sizes. From the left, 16x16, 32x32, 64x64 and
96x96 respectively.

This mask can be applied more than once. It has been shown that applying this mask four times
fits best for all phase values in the image (Haacke et al., 2009b). An example of SWI images is
shown in figure 3.7. This is an MS patient imaged at 4T. The SWI image is mipped over 8 slices
to better enhance the vessel connectivity between slices, presenting a new contrast that is not
seen in either magnitude or phase images alone.
The link between the susceptibility of a material and the final MR image has been
carefully tailored throughout the chapter. The discussion has shown that the presence of
magnetically susceptible material such as iron for instance, can be visualized and "relatively"
measured by phase shifts in the MR signal. The SWI acquisition and processing scheme tries to
reduce the effect of other phase contributors (flow compensation, high pass filter, short TE and
TR, low flip angle), to make sure that what we measure is reliable. In the next chapters, we will
use the phase images to assess iron content in the brain. The word "relatively" which was
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emphasized before informs the reader that an absolute quantification of iron derived from phase
is not robust yet due to many contributing factors in the imaging method itself and the imaged
object (Haacke et al., 2009b).

Figure 3.7: Magnitude, phase and SWI images (mipped over 8 slices) showing sclerotic white
matter lesions (red arrows), created from the 3D GRE sequence described in this chapter.

In the next chapter, we will assess the contrast to noise ratio and the signal to noise ratio
of the SWI images compared to conventional MRI, and test its ability to image the midbrain and
resolve its different structures and substructures.
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Chapter Four
CHARACTERIZING THE MESENCEPHALON USING
SUSCEPTIBILITY WEIGHTED IMAGING
Introduction
In recent years, imaging of neurodegenerative disorders like Alzheimer’s, Parkinson’s
and Huntington’s disease have attracted much attention. Most of these diseases’ pathological
landmarks have been found in parts of the brainstem, especially in the mesencephalon. The
substantia nigra, which is the primary source of dopamine synthesis and whose pathways are
known to involve iron (Sofic et al., 1991) is affected in a number of diseases. Its atrophy and/or
altered functionality could lead to a disruption of dopamine balance in the brain and may lead to
motor and/or cognitive deficits. Two other structures involved in coordinating motor function are
the crus cerebri (located lateral to the substantia nigra) and the red nucleus, which has
connections to the cerebellum and the spinal cord via a number of key motor tracts. The
progression of Alzheimer’s, Parkinson’s and Huntington’s diseases has been thought to be
associated with an increase in iron content in the red nucleus and substantia nigra (Sohmiya et
al., 2004). Therefore, the ability to differentiate among mesencephalic structures should be
helpful in visualizing specific damage to these structures and establishing better diagnoses for
neurodegenerative diseases (Kim et al., 2007; Semnic et al., 2005; Sofic et al., 1991; Sohmiya et
al., 2001; Sohmiya et al., 2004).
To date, T1-, T2- and T2*-weighted magnetic resonance imaging (MRI) methods have
been used to image the mesencephalon (Gelman et al., 1999). Generally, the workhorse in
anatomical measurements has been 3D T1-weighted gradient-echo imaging. This approach is
often done with a magnetization-prepared, rapid acquisition gradient-echo (MP RAGE) approach
that uses an inversion pulse followed by the slice encoding gradients and then loops over the
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phase encoding gradients (Mugler and Brookeman, 1990). Alongside MP RAGE, a short-TR,
low flip angle, gradient-echo fast low-angle shot (FLASH) sequence with radiofrequency
spoiling can be used for T1 contrast (Frahm J, 1986). As an example of applied research in
imaging the mesencephalon, Shibata, et al. (Sasaki et al., 2006) used T1-weighted imaging to
investigate changes in neuromelanin levels in the lower tegmentum. Unfortunately, such T1based sequences provide rather poor information about upper mesencephalic structures where
high vascularization is present (Sofic et al., 1991) and where accurate differentiation between
gray matter structures is needed. T2 imaging shows the substantia nigra and the red nucleus quite
well but does not distinguish between their substructures (such as the pars reticulata and pars
compacta of the substatia nigra, or the capsule and interior structures of the red nucleus). Today,
at 3T and 4T, resolution can be pushed easily to 0.5 mm x 0.5 mm x 2 mm. This level of
resolution should allow for good 3D imaging of the mesencephalon given that the structures of
interest are only about 1 cm thick and require thin slices to be evaluated in detail.
Recently, a method called susceptibility weighted imaging (SWI) has been developed to
enhance contrast in T2*-weighted imaging (Haacke et al., 2004; Reichenbach et al., 1997). It is
acquired using a fully flow-compensated gradient-echo imaging method in order to pick up extra
information from local susceptibility variations in tissue via the phase image (in the past, phase
was usually discarded as not being useful clinically). Due to the fact that the phase signal is
sensitive to local field change effects, phase data are used as a new source of contrast. When the
MR data are collected, there are both real and imaginary components. These are then rearranged
to create magnitude and phase images. The phase images contain information about local static
field variations, geometry-induced field variations and the local tissue susceptibility of interest
here. The first two components tend to have low spatial frequency and can be mostly eliminated
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by applying a high pass filter. The resulting high pass filtered phase images can be considered to
be a reasonable representation of the local tissue susceptibility (Haacke et al., 2007).
Susceptibility changes can be caused by deoxygenated blood (due to the paramagnetic nature of
deoxyhemoglobin), brain iron (in the form of ferritin or hemosiderin proteins), or calcium (which
is diamagnetic). The SWI filtered phase images are themselves of anatomic interest and can be
used to measure the putative non-heme iron content in the basal ganglia and in other areas of the
brain (Haacke et al., 2007). The SWI filtered phase images can also be modified to produce a
phase mask that is then multiplied into the magnitude images to create a set of SWI magnitude
images (Haacke et al., 2004; Reichenbach et al., 1997). These new images now carry unique
information from the phase and provide improved contrast between veins, arteries and
surrounding tissue.
Although SWI has been used to show individual images of the mesencephalon previously
(Abduljalil et al., 2003; Chakeres et al., 2002; Haacke et al., 2007; Haacke et al., 2004; Rauscher
et al., 2005), no one has yet performed a systematic and quantitative analysis of the contrast
between the different structures of the midbrain. In the present work, we quantify contrast
between and within structures in the human mesencephalon at 1.5T and 4T using SWI.
Specifically, the following structures will be shown on SWI filtered phase images: the red
nucleus and its various vascular subcomponents, the capsule of the red nucleus, the substantia
nigra pars compacta, the substantia nigra pars reticulata, the crus cerebri, the medial geniculate
body, the sub-thalamic nucleus, the lateral geniculate body and the fascicula nigrale (pallidalnigral pathway). The contrast of these structures, provided by SWI filtered phase images, will be
shown to correlate with the contrast defined by the vascular content in the mesencephalon,
highlighted by the India ink staining of cadaver brains in Duvernoy’s work (Duvernoy, 1999).
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High-resolution examples covering the entire mesencephalon (5 slices, each 2 mm thick) will be
shown at both 1.5T and 4T.

Materials and Methods
Five volunteers (23 to 27 years old for SWI; 36 to 56 years old for T1 and T2) were
imaged at 1.5T (Siemens Sonata, Erlangen, Germany) and another five volunteers (23 to 27
years old for SWI; 29 to 45 years old for T1 and T2) were imaged at 4.0T (Bruker/Siemens
Medspec, Ettlingen, Germany). Institutional review board approval was obtained and all
participants signed the appropriate consent forms. All images were collected in a predominantly
axial orientation following the AC/PC line. Detailed imaging protocols are given below.

1.5T imaging protocol
A segmented echo-planar imaging sequence (5 echoes) was used for the SWI scans. The
sequence was collected with a resolution of 0.5 mm by 0.5 mm by 2 mm, 64 slices, TR = 71 ms,
TE = 40 ms, BW = 130 Hz/pixel, FA = 20°, a matrix size of 512x512, and an acquisition time of
8 minutes, 57 seconds. The conventional 3D T1-weighted images were collected with a
resolution of 0.5 mm by 0.5 mm by 2 mm, 64 slices (with a parallel imaging factor of 2), TR =
20 ms, TE = 5.58 ms, BW = 130 Hz/pixel, FA = 25o, a matrix size of 512x512, and an
acquisition time of 4 minutes, 11 seconds. The T2 data were collected with a resolution of 0.5
mm by 0.5 mm by 4 mm, 25 slices, TR = 5230 ms, TE = 106 ms, FA = 160 o, BW = 130
Hz/pixel, a matrix size of 512x384, and an acquisition time of 4 minutes, 47 seconds.
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4T imaging protocol
A fully flow-compensated gradient-echo sequence was used with parallel imaging (for a
factor-of-two drop in acquisition time) for the SWI scans. The sequence was collected with a
resolution of 0.5 mm by 0.5 mm by 2 mm, 64 slices, TR = 24 ms, TE = 15ms, BW = 80
Hz/pixel, and FA = 12o, a matrix size of 512x512, and an acquisition time of 12 minutes, 52
seconds. The 3D T1-weighted images were collected with a resolution of 0.5 mm by 0.5 mm by
2 mm, 64 slices (with a parallel imaging factor of 2), TR = 20 ms, TE = 5.58 ms, BW = 130
Hz/pixel and FA = 25o, a matrix size of 512 x 512, and an acquisition time of 4 minutes, 47
seconds. The T2 data were collected with a resolution of 0.8 mm by 0.8 mm by 3 mm, 36 slices,
TR = 4950 ms, TE = 72 ms, FA = 150o, BW = 120 Hz/pixel, a matrix size of 320x240 and an
acquisition time of 4 minutes, 53 seconds.

Evaluating the SWI data
The data were processed with in-house Visual C++-based software called SPIN (Signal
Processing In NMR). SWI data were processed using a 64 x 64 high-pass filter to create a
filtered phase image. Window level adjustments were made to view the best image contrast. In
measuring contrast, the signal for a given structure was measured from a 100-200 pixel region of
interest (ROI) drawn within the structure of interest. For all sequences, contrast-to-noise ratios
(CNRs) were calculated between a variety of structures as the signal difference between two
structures (Sa, Sb), divided by the noise (σ), or (Sa – Sb)/σ. The noise was calculated as 0.8 times
the mean of a 100-200 pixel ROI outside of the head and away from phase encoding artifacts (a
region where only noise was present). Since the structures measured are bilateral, the CNR for a
given structure was measured from the ROI having the best apparent contrast. Where the
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appropriate contrast was visible, we calculated the CNR between: (1) the red nucleus and the
intermediate area (separating the red nucleus from the substantia nigra); (2) the red nucleus and
its capsule; (3) the capsule of the red nucleus and the intermediate area; (4) the substantia nigra
and the intermediate area; (5) the substantia nigra and the crus cerebri; (6) the substantia nigra
pars compacta and the substantia nigra pars reticulata; (7) the substantia nigra pars compacta and
the intermediate area; (8) the substantia nigra pars reticulata and the crus cerebri; (9) the lateral
and central aspects of the medial geniculate body; and (10) the central aspect of the medial
geniculate body and the intermediate area. Background noise was also evaluated outside the
image and compared with the standard deviation seen inside the ROI. Each subject data set was
carefully scrutinized to find the five or six slices associated with the mesencephalic structures of
interest. The MR results were compared to the measurements of mesencephalic capillary density
in cadaver brains by Duvernoy, who (using 3-mm-thick slices) performed India ink staining and
5% gelatin injections to highlight anatomical differences.

Results
The area reviewed in the mesencephalon is shown in figure 4.1. A comparison between
T1, T2 and SWI contrast, alongside Duvernoy’s India ink-stained results, is shown in figure 4.2.
Overall, there is little contrast in the T1 images, while the T2 images show good contrast
for the red nucleus and substantia nigra. The SWI images, however, show good contrast with
details of the internal structures visible for the red nucleus, the substantia nigra, the crus cerebri
and the medial geniculate body (figure 4.3). On the SWI filtered phase images, we see the red
nucleus broken up into a highly vascularized portion and a less-vascularized portion. The images
from Duvernoy show the horseshoe effect of the vascularized red nucleus, and this is well-
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mimicked in the SWI results (figure 4.4C, D: arrow 4.4a). Also, the connecting tissue from the
substantia nigra is seen to course laterally through the crus cerebri (figure 4.4C, D: arrow 1). The
substantia nigra can occasionally be seen as having two parts: the pars reticulata (the lateral
portion, containing more iron; figure 4.4: arrow 2a) and the pars compacta (the medial portion,
containing slightly less iron; figure 4.4: arrow 2b). Similar to the behavior seen in the red
nucleus, the dark, more vascularized region in the lateral aspect of the medial geniculate body is
visualized in SWI (figure 4.4: arrow 6). Finally, the pallidal-nigral pathway (the fascicula
nigrale)—which may transport iron between the substantia nigra and globus pallidus—is also
seen (figure 4.4B-D: arrow 5). Much of these structures’ anatomy changes with each 2 mm-thick
slice and many details would not be visible with thicker slices.
In terms of capillary density, the patterns shown in Duvernoy’s work appear to be
duplicated in the SWI phase images. In addition to the differentiation displayed within the
substantia nigra, the red nucleus is seen to contain two regions: a highly vascularized horseshoe
area and a brighter central region (figure 4.4C, D: arrows 4.4a, b). In general, the local decrease
in phase correlates with the darkened patterns of vascularization in Duvernoy’s work.
In terms of quantitative tissue differentiation, we have found that SWI provides good
contrast, especially when considering all components of the mesencephalon. CNR results are
provided in Table 4.1 for 1.5T and Table 4.2 for 4T. The effect of improved SNR at high field
and reduced T2 is evident in the images themselves wherever iron content is high. In SWI, the
CNR generally increases from 1.5T to 4T, but this increase is dependent on the structure of
interest. In some cases (in the medial geniculate body, for example) the CNR increases by a
factor of three from 1.5T to 4T. In other cases, there is only a 25% increase in CNR (in the red
nucleus, for example).
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Figure 4.1: A-F, The midbrain as a region-of-interest on 4T SWI magnitude images shown in
sagittal and coronal sections, with and without slice locators. Arrows 1, 2 and 3 point to the red
nucleus, the subthalamic nucleus and the substantia nigra, respectively.
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Figure 4.2: A comparison of one region of the mesencephalon for different sequences and field
strengths with Duvernoy's stained cadaver brain results. A, T1 at 1.5T; B, T1 at 4T; C, T2 at
1.5T; D, T2 at 4T; E, Duvernoy's India ink-stained image; F, SWI magnitude at 1.5T; G, SWI
high-pass filtered phase at 1.5T; H, SWI magnitude at 4T; I, SWI high-pass filtered phase at 4T;
J, Duvernoy's India ink-stained image. (Images (E) and (J) obtained with kind permission of
Springer Science and Business Media.)

Figure 4.3: A comparison between adjacent slices in SWI magnitude and high-pass filtered
phase images at 1.5T and 4T with Duvernoy's India ink-stained results. A, Magnitude SWI at
1.5T; B, High-pass filtered phase at 1.5T; C, Magnitude SWI at 4T; D, High-pass filtered phase
at 4T; E, Duvernoy's results. Only three unique images from Duvernoy are shown here since his
slice thickness is 3 mm. The third and fourth images from the top are identical. (Images in
column (E) obtained with kind permission of Springer Science and Business Media.)
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Figure 4.4: A comparison of SWI high-pass filtered phase images (B and D) with Duvernoy's
India ink-stained results (A and C). Anterior (A and B) and posterior (C and D) mesencephalic
structures are indicated. 1: crus cerebri; 2a: substantia nigra, pars reticulata; 2b: substantia nigra,
pars compacta; 3: capsule of the red nucleus; 4a: red nucleus (vascularized region); 4b: red
nucleus (non-vascularized region); 5: fascicula nigrale; 6: medial geniculate body; 7: superior
colliculus. (Images (A) and (C) obtained with kind permission of Springer Science and Business
Media.)
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Table 4.1: 1.5T Contrast-to-Noise Ratio (CNR) measurements. The first row for each sequence
represents the mean in a given region-of-interest (ROI), while the second row represents the
standard deviation (SD) in the same ROI. (No contrast for the given ROIs was observed in the
gradient echo T1 data.)

Sequence

T2 tse
T2 tse SD
SWI
SWI SD

Red Nucleus CNR
IA/RN
IA/RN
RN/RN
capsule
capsule
4.13
—
—
1.23
—
—
—
1.43
4.54
—
0.73
1.62

Substantia Nigra CNR
IA/SNc CC/SNr SNc/SNr
6.19*
1.44*
5.58
0.6

4.97*
1.48*
2.84
0.75

—
—
3.74
1.46

Medial Geniculate CNR
CMG/LMG CMG/IA
—
—
1.38
1.47

—
—
0.45
0.35

Table 4.2: 4T Contrast-to-Noise Ratio (CNR) measurements. The first row for each sequence
represents the mean in a given region-of-interest (ROI), while the second row represents the
standard deviation (SD) in the same ROI. (No contrast for the given ROIs was observed in the
gradient echo T1 data.)
Sequence

T2 tse
T2 tse SD
SWI
SWI SD

IA/R
N
3.36
0.77
—
—

Red Nucleus CNR
IA/RN
RN/RN
capsule
capsule
—
—
—
—
1.13
5.85
1.34
2.23

Substantia Nigra CNR
IA/SNc CC/SNr SNc/SNr
4.53*
0.48*
8.75
1.67

6.27*
1.64*
5.19
1.51

—
—
3.56
1.08

Medial Geniculate CNR
CMG/LMG CMG/IA
—
—
4.57
2.49

—
—
1.64
0.89

RN: red nucleus; SNc: substantia nigra, pars compacta; SNr: substantia nigra, pars reticulata; IA:
intermediate area between RN and SN; CC: crus cerebri; LMG: lateral aspect of the medial
geniculate body; CMG: central aspect of medial geniculate body. Empty data boxes show that
CNR between certain structures could not be calculated because the structures could not be
detected.
* Since SNc and SNr were not seen for T2, CNR is recorded here for IA/SN and CC/SN.
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Discussion
Iron plays a key role in many neurological processes. It is of great interest in the study of
neurodegenerative disease today and iron remains a topic of high interest in the medical
community. SWI offers a way to look at iron content that is different from T1, T2 or T2* maps.
The SWI filtered phase images are a sensitive means to not only visualize the presence of iron
but also to quantify it (Haacke et al., 2007; Haacke et al., 2005; Ogg et al., 1999). The non-heme
forms of iron that are likely seen with MR are ferritin and hemosiderin. Ferritin appears to be
seen predominantly in the basal ganglia and primary motor cortex. Gray matter has more ferritin
than white matter, although there are indications that ferritin is also present in white matter
(Haacke et al., 2007). Iron in transferrin or in glial cells may be non-magnetic and therefore
invisible to MR imaging. This may explain why white matter appears to have less iron than gray
matter on MRI, while staining reveals the opposite (Haacke et al., 2005).
Based on the data collected at 1.5T and 4T, we can see that highly vascularized areas,
like the vascularized region of the red nucleus (as specified in Duvernoy’s work), become more
prominent or darker on SWI filtered phase images at higher field (figures 4.2, 4.3). Thus, the
contrast between the red nucleus and the surrounding brain tissue improves with increasing field
strength. In fact, we are able to see the capsule of the red nucleus at 4T in the magnitude images
for the first time (figures 4.2H, 4.3C). (SWI filtered phase images can visualize the capsule at
1.5T, but the magnitude images do not). Although the CNR is often large than 4:1 (the CNR
needed to be able to visualize clearly one structure from another) this was not always the case.
Further, the T2 images had thicker slices and hence their CNR is overestimated by the ratio of
their thicknesses compared to the 2mm used in the SWI scans. Further, the CNR at 4T is even
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further overestimated by a factor of 1.6 because of the lower resolution of 0.8mm compared to
0.5mm with the SWI scan.
Hypothetically, if we are able to prove that iron causes a reduction in T2 or T2* with
increasing magnetic field strength, we would be able to predict that the areas with the higher
capillary density would appear darker at high field. An interesting study would be to investigate
the relationship between iron and vascular density. E. Sofic (Sofic et al., 1991) and C. M. Morris
(Morris et al., 1992) showed that large ferritin deposits are associated with the small blood
vessels of the basal ganglia. The strong correspondence of SWI phase and high-field magnitude
images with Duvernoy’s India ink-stained images (Duvernoy, 1999) and Morris, et al.’s results
(Morris et al., 1992) therefore suggests that the non-heme iron visualized in MRI in normal brain
is most likely due to ferritin associated with the vascular network. If this hypothesis is verified,
these SWI magnitude and filtered phase images may prove to be an important means by which to
understand microvascular effects in neurodegenerative diseases.
In conclusion, the high iron content in the red nucleus and substantia nigra leads to a
susceptibility change in the tissue that causes a reduction of the phase in these regions in the SWI
filtered phase images. This phase change can be used either by itself or to create a magnitude
susceptibility weighted image. In either case, this property leads to improved contrast in the
mesencephalon using SWI. The improved contrast in the phase images may provide a means by
which to monitor changes in the mesencephalon with age or disease state.
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Chapter Five
MULTIPLE SCLEROSIS
Chapter overview
Chapter 2 covered the importance of iron in the human body and brain and the potential
consequences of free iron deposition being toxic and leading to the development of
neurodegenerative diseases. In this chapter, we will present a broad overview of one such
disease, multiple sclerosis (MS). The definition of MS, its types as well as its clinical
manifestations, will be discussed. The main areas of ongoing research into MS pathogenesis will
be emphasized including the immunological, cellular, molecular, neuronal as well as vascular
involvement.

Introduction
MS is widely accepted as an autoimmune, inflammatory, demyelinating disease of the
central nervous system (CNS) (Noseworthy et al., 2000b). This pathology is recognized as the
most common cause of progressive neurologic disability in young adults worldwide. What
initiates the disease and the sequence of events underlying the development of MS is not yet
well-established (Noseworthy et al., 2000b). However, technological progress as well as the
outcomes of successful research has been able to shed some important insights on most factors
involved in the pathology of this complex disease. For instance, although there is no precise
description or understanding of the nature of this disease, a lot of work has already been done to
provide a reasonable clinical, immunological, neurological and vascular understanding of the
disease.
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Multiple Sclerosis: Clinical Landmarks
5.1 – Different types of MS
5.1.1 Definitions
For a long time, four main clinical phenomena have been recognized as expressed in the
course of multiple sclerosis: initial attack, remission, relapse and progression (Confavreux and
Vukusic, 2008). Clinically, relapses, also known as exacerbations or attacks, are usually
associated with focal inflammation of acute lesions or reactivation of older lesions. These attacks
usually end with a remission which can be either partial or complete. The duration of these
exacerbations is usually more than 24 hours although 48 hours is the minimum required duration
to be considered as attacks (Poser et al., 1983). The emergence of fatigue alone is not enough to
be considered a relapse. The fourth phenomenon, progression, is defined as the steady increase in
symptoms and signs for more than 6 months (Poser et al., 1983). In other words, progression is
the clinical manifestation of chronic, progressive, diffuse degeneration of the CNS.
The occurrence of these relapses and progression defines two distinct phases in the
course of MS: the relapsing-remitting (RR) phase, which is characterized by alternating relapses
with episodes of clinical inactivity, and the progressive phase which occurs after consecutive
relapses and remissions. In some circumstances, steadily progressive course can be reached right
from clinical onset. To summarize:
1. Relapsing-remitting (RR) MS is characterized by well-defined relapses with full remissions or
with some deficits on recovery.
2. Secondary progressive (SP) MS starts with a relapsing-remitting disease course and
progresses with some chances of minor remissions, occasional relapses and sometimes plateaus.
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3. Primary progressive (PP) MS is characterized by disease progression from initial clinical
onset with some temporary improvements and occasional plateaus.
4. Progressive-relapsing (PR) MS is characterized by progressive disease from the beginning of
clinical symptoms, with clearly defined relapses, and continuing progression between relapsing
periods.
Although it is still under review by MS experts, clinically isolated syndrome is defined
for individuals who have a first neurological (monofocal or multifocal) episode lasting 24 hours
or more as a result of inflammation in the CNS. Monofocal episode might be limited to an optic
neuritis attack, while multifocal episode might reveal weakness on one side in addition to optic
neuritis for example. CIS is considered an early sign exhibited by those individuals that might
develop one of the MS types mentioned above. However, if caught at that stage, these
individuals can be treated early to avoid or delay the onset of clinically definite MS.

5.1.2 Comparison between MS types
At first glance, relapses appear to be the major player in MS pathology. Furthermore,
many relapse-related factors are associated with the rapid accumulation of irreversible disability
(i.e., an incomplete recovery from the initial neurologic episode, a short interval between the first
two episodes, and a high rate of relapses during the first years of the illness (Weinshenker et al.,
1991)). Evidence from the PP form of MS indicates that irreversible disability may occur without
superimposed relapses. The rate of disability accumulation in these forms of the disease is
similar to that seen in the PR form (Cottrell et al., 1999). In general, relapses occur in an
unpredictable way, since their frequency varies between individuals as well as within a given
individual. Apparently, progression pursues its course independent of individual relapses,
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whereas relapses can be superimposed over and above the process of progression. In RRMS, a
short-term confirmed increase in disability depends primarily on relapses and is often reversible.
To get a better understanding of the difference between MS types, a comparison summary is
provided below for the cases where major differences are recognized.

5.1.2.1 Secondary-progressive MS and relapsing-remitting MS
SPMS and RRMS share the same distribution of initial symptoms during the RR phase,
the degree of remission from the first relapse, and the period between the onset and the second
neurologic episode (Minderhoud et al., 1988). Most RRMS patients eventually become SPMS.

5.1.2.2 Primary-progressive and progressive-relapsing MS
No major differences could be observed clinically and demographically, when comparing
these two forms of MS. This holds true for the rates of irreversible progression of PRMS and
PPMS. However, PRMS tends to start at earlier age compared to PPMS (median age 37
compared to 41). (Confavreux et al., 1980).

5.1.2.3 Secondary-progressive MS and PPMS
These two types of MS do actually differ. For instance, the clinical manifestation, the
onset age and the time it takes to reach a debilitating state are different between SPMS and
PPMS (Confavreux and Vukusic, 2006). The latter is more dominant in male subjects
(McDonnell and Hawkins, 1998). The former, on the other hand, tends to have a more rapid
disability accumulation rate and occurs at a younger age than the latter.
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5.2 - MS patients
5.2.1 Age at onset of Multiple Sclerosis
From a percentile perspective, the distribution of patient onset by age is as follows: 10%
for 20 years old or younger; 70% between the ages 20 to 40 years old and 20% for subjects 40
years and older. Any onset after the age of 55 years is more likely to be questioned whether this
is indeed an MS attack (Confavreux and Vukusic, 2006, 2008). Females often seem to have a
slightly younger mean age at onset than males. Furthermore, the female/male ratio is usually
found to decrease as age at onset increases.

5.2.2 Genetic and environmental factors
Multiple sclerosis has always been thought to be more common in women and whites
(Frohman et al., 2008). Although the former still hold true, newer studies reported that MS is
more common in African American females and more threateningly progressive in African
Americans in general (Langer-Gould et al., 2013). They believe that this might be related to their
vitamin D deficiency due to the darker skin tones. On the other hand, Hispanic and Asian
individuals are at lower risk compared to other races. The disease is also common within families
with a known history of MS which may be due to the set of immune response genes (built upon
the exposure to triggering factors such as viral infections).

5.2.3 Initial symptoms and signs
Initial symptoms in MS (Confavreux and Vukusic, 2006) may be isolated optic neuritis
(15%), isolated brainstem dysfunction (10%), isolated dysfunction of long tracts (50%), and
various combinations of these symptoms (25%). There was no influence of gender on initial
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symptoms. However, an obvious influence of age at onset has consistently been found
(Confavreux and Vukusic, 2008).

5.2.4 Initial course
It is estimated that the initial course of MS is RR in 85% of the cases and progressive in
15% (Confavreux et al., 1980). RRMS is more common in female subjects while progressive MS
is more prominent in men. Subjects diagnosed with long tract dysfunction (presence of motor,
sensory, or sphincteric disturbances) tend to follow the progressive course of the disease. On the
other hand, patients diagnosed with optic nerve and brainstem symptoms are mostly diagnosed
with RRMS (Confavreux et al., 1980).

5.2.5 Remission
The duration of the ongoing neurologic episode is the key element in the MS prognosis
(the probability of improvement) (Kurtzke et al., 1973). Usually, there is a high chance of a
second neurologic episode immediately following the initial episode (but not in the cases of optic
neuritis), and this probability progressively decreases afterwards. Clinical factors (such as gender
and age) may also influence the rate of occurrence of the second neurologic episode in MS, but
according to many studies, no clinical factor has had a strong correlation with initial symptoms,
degree of recovery from the initial episode, and a RR or SP overall course of the disease
(Confavreux et al., 1980). The probability of developing a second episode (although lower) was
similar for optic neuritis, spinal cord syndromes, and brainstem-cerebellar symptoms (Tintore et
al., 2005). This probability increases with the number of T2 lesions and volume on the MR
image (Kappos et al., 2006). On the other hand, juxtacortical, infratentorial and periventricular
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lesions do not predict whether a second neurologic episode will take place or not (Barkhof et al.,
1997).

5.2.6 Relapse frequency
A huge variation in relapse frequency has been seen in MS patients. In RRMS, the yearly
rate is estimated on average to be equal to 0.5 relapses per year. As the disease duration
increases, the relapse rate tends to decline overtime. However, this statement has been
contradicted by a 3-year longitudinal study which showed that the relapse rate was not
influenced by overall disease duration (Goodkin et al., 1989).

5.2.7 Onset of progression
The time to enter the secondary progression phase is estimated to be 19 years on average
following an RR onset in MS. However, the time to onset of progression has been shown to be
strongly age dependent. For instance, patients diagnosed with RRMS at an older age tend to
enter the progressive phase more rapidly (Confavreux et al., 1980; Trojano et al., 1995). Each
year, 2% to 3% of the RRMS patients enter secondary progression. This rate is highly associated
with gender, initial clinical symptoms, rate of recovery after the initial attack, the time period
between the initial and secondary attack, as well as the relapse frequency (Confavreux et al.,
1980; Trojano et al., 1995).

5.2.8 MS in children
Although it is rare, onset of MS in children has been reported (Hynson et al., 2001). The
ratio of female to male is higher in children (3:1) compared to adult subjects (2:1). A difference
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in clinical outcomes is seen between children and adults in the early stages of the disease
although a similar pace is seen when the progressive phase is reached. Childhood onset MS
patients have been reported to reach the progressive phase at a younger age compared to adult
onset MS patients (Renoux et al., 2007).

5.2.9 Survival in MS
After being diagnosed with MS, the median survival for MS patients is 28 years for male
and 33 years for females (Bronnum-Hansen et al., 2004). Compared to healthy controls, MS
patients tend to live 10 years shorter compared to the age matched healthy controls. In addition,
median survival from onset is higher in RRMS compared to PPMS (Grytten Torkildsen et al.,
2008).

5.2.10 Living with MS
The person with MS can go through normal life events as all other members in society.
This includes natural, accidental and interventional events (such as pregnancy, stress, trauma,
infection anesthesia, surgery, and vaccinations). However, these patients are more susceptible to
infection, which re-initiates the MS cascade and results in recurring relapses (Confavreux and
Vukusic, 2006).

Multiple Sclerosis: Immunological, Cellular, Molecular and Vascular Involvement
5.3 Immunological approach
MS has been diagnosed as a multiphasic disorder, producing clinical attacks at different
times in a patient’s life, and affecting distinctly different CNS injury targets. Therefore, the
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diagnostic criteria have been expanded to increase the sensitivity and specificity of clinical
diagnosis (Polman et al., 2005). In the past, MS was only being declared at a time when a patient
experienced multiple attacks. Nowadays, patients are classified as having MS when they present
a single event that is not explained by an alternative etiology, or when there is evidence of
disease seen anatomically using conventional MR imaging criteria. For instance, clinically
isolated demyelinating syndrome is most typically associated with clear brain or spinal cord
lesions (Frohman et al., 2003). However, there is little debate today that MS is radiographically
more active than what is observed clinically over time. The advances in nonconventional MR
imaging techniques shows a more global MS pathology and it is believed that MS may not be
truly characterized by ‘‘multiple’’ areas of sclerosis, but rather a ‘‘diffuse’’ representation of
sclerosis. One of the known landmarks of this disease is the mononuclear cell infiltrates that
seem to assemble around post-capillary venules within the CNS. This is facilitated by the
upregulation in the expression of adhesion molecules on cerebrovascular endothelium, serving as
a scaffolding for the migration of these cells in the brain and spinal cord (Frohman et al., 2006).
Once in the CNS, these cells contribute in a complex injury cascade that seems to result in
inflammation and theretofore, leading to neurodegeneration. Hence, acute relapses are thought to
be related to the development of inflammation within the CNS tract systems (Noseworthy et al.,
2000a).

5.3.1 Inflammatory mechanisms underlying tissue injury in multiple sclerosis
In MS, it is believed that there is a major change in many regulatory mechanisms which
disable the proper function of the immune system in identifying and neutralizing foreign bodies.
In addition, the inability of the immune system to recognize self-epitopes leads to a series of
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inflammatory reactions, and hence tissue injury. As such, failure of these mechanisms has been
considered as a central hypothesis within the path of autoimmune disorders.
In MS patients, T cells (Treg) are actively primed against myelin antigens (Lovett-Racke
et al., 1998). Their presence seems to affect and correlate with the clinical activity and outcome.
These pathogenic lymphocytes become resistant to apoptosis, and fail to protect against autoaggressive responses. Under these circumstances, one would think that the depletion of T cells
would be a possible treatment plan to treat MS patients. However, this does not hold true given
the importance of these cells in maintaining immune homeostasis (Noseworthy et al., 2000a).
In this section, we will discuss various histopathologic substrates which were unveiled
from human MS brain investigations. The fork head box P3 transcription (Foxp3) and protein
levels, which is required for the development and maintenance of the T cells compartment, were
reported decreased in patients with MS (Fontenot and Rudensky, 2004; Frohman et al., 2006).
Another study was conducted investigating the population of regulatory T cells (Brusko et al.,
2005). This study showed that the parenchymal CNS infiltrate consisted of B and T cells along
with macrophages, with the CD8 T cells being enriched and expanded in MS (Babbe et al.,
2000). This study agreed with what is classically reported in RRMS (Crawford et al., 2004). In
contrast, the improper function of CD8 regulatory T-cells perturbs the effectiveness of the
immune system, inducing a pro-inflammatory state in MS. This was confirmed when restoration
of CD8 regulatory T cells worked as an anti-inflammatory mechanism (controlling the excessive
T cell response) and decreased clinical symptoms (Karandikar et al., 2002).
Another component of the immune system which seems to be involved in the
pathogenesis of MS is the humoral immune response. Evidence of antibody synthesis was
identified in the cerebrospinal fluid (CSF) of MS patients which seemed to be compartment-
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driven. The presence of

these oligoclonal bands in the clinically isolated demyelinating

syndrome phase strongly predicts the conversion to clinically definite MS (Villar et al., 2008).
Humoral immune responses involve the production of antibodies resulting from a series of
complex molecular changes within B cells. Under altered regulatory control mechanisms, the
immune system might generate B cell-derived antibodies targeted against infectious epitopes,
which can be structurally homologous to self-tissue epitopes, thereby establishing the possibility
of cross-reactivity and the development of auto-aggressive immune responses (Levin et al.,
2002) and lead to humorally mediated tissue injury in MS. This process has been documented in
B cells derived from the cerebrospinal fluid of MS patients (Owens et al., 2003) and has been
emphasized by a recent study that showed that a selective monoclonal antibody against a B-cell
developmental protein (CD20) led to a reduction in both clinical and imaging measures of
disease activity (Hauser et al., 2008).

5.3.2 Epitope spreading
The alteration of the antigenic specificity of immune responses over the course of the
disease seems to be relevant to the pathophysiology of MS. These changes take place in the
cellular and the humoral levels of the immune response to ensure the recognition and
neutralization of infectious agents. However, under pathogenic conditions, these reactions might
be targeted against self-antigens, enhancing the reliability of such responses and maintaining the
disease activity in the MS patients (Frohman et al., 2008).
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5.3.3 Lymphocyte nomenclature and phenotype
The immune system provides surveillance diffusely and compartmentally to the entire
body. TH1 and TH2 phenotypes play a major role in characterizing the behavior of T cells. TH1
cells release proinflammatory cytokines (interferon-γ, tumor necrosis factor-β, interleukin (IL) –
12). IL-12 (increase expression) and tumor necrosis factor-β are thought to be associated with
MS-related disease activity (Balashov et al., 1997). MS patients show augmented expression of
IL-12 when compared with cells derived from control subjects (Comabella et al., 1998). On the
other hand, TH2 phenotype (elaborating IL-4, IL-5, IL-6, and IL-1344) is considered as antiinflammatory cytokines. TH17 cells that produce IL-17, under the influence of IL-23 or IL-6 and
transforming growth factor-β, are gaining a great deal of prominence as pathogenic cells in MS
and other diseases. ‘‘TH3’’ cells also seem to be involved in down-regulation of inflammation.
Interferons’ anti-inflammatory immune effects have been assessment in many studies (Duda et
al., 2000; Steimle et al., 1994). In an MS trial, they used interferon-γ to treat a RRMS and was
shown to initiate new attacks through cellular and humoral immune responses (Panitch et al.,
1987). On the other hand, treatment with a different interferon-β seems showed reduced disease
activity and clinical symptoms (Duda et al., 2000). Nowadays, modulation of other type of T
cells are being studied (TH17, IL-17, OL22) which seem to play an important role in the
pathogenesis of MS (Polman et al., 2005).

5.4 Cellular approach
Cellular trafficking across different tissues of the body is achieved through molecular
interventions, which stabilize the cells and make them ready for migration to specific organs. In
MS, and due to the breakdown of the BBB, an expanded number of cells enter the brain and
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spinal cord. Part of those cells migrates through the expression of adhesion molecules on the
endothelial surface of postcapillary venules. The adhesion molecules on the endothelium,
selectins, facilitate the slowing and rolling of the mononuclear cells (lymphocytes and
macrophages) on the vessel surface. These cell surface integrin receptors then interact with
vascular cell adhesion molecule making the mononuclear cells more stabilized (Noseworthy et
al., 2000a). Once attached to the endothelium, metalloproteinases digest fibronectin and
basement membrane collagen and creates a channel of passage for the migration of into the brain
and spinal cord. Once they reach the CNS, these cells mediate damage through a variety of injury
cascades involving cytokines, chemokines, free radicals, superoxides, antibody- and
complement-dependent reactions, and changes in ion channels and excitatory amino acid
mechanisms (Frohman et al., 2006).
In the pathology of MS, the damage happens in both white matter and gray matter.
Therefore, inflammation, degeneration as well as the adaptation to injury response are seen in
both areas. The damage occurs as a result excitotoxicity leading to irreversible damage to the
axons; hence neurodegeneration. From a cellular trafficking point of view, when demyelination
occurs, axons recruit new sodium channels to recover proper function (Stys et al., 1992). The
system, therefore, senses an exaggerated amounts of sodium, thereby driving the molecular
mechanisms to reduce sodium. All these observations lead to more axonal injury and
contributing to the progress of the disease (Frohman et al., 2008).
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5.5 Molecular approach
5.5.1 Iron
As we learned from chapter 2, iron is the most abundant metal in the human brain, and
plays an important role in many metabolic and functional processes (Stankiewicz et al., 2007).
For instance, iron was shown to be a necessity for the synthesis of oligodendrocytes and a key
factor in oxygen transport. Ferritin and hemosiderin are considered the two forms of iron storage
elements in the cells (Quintana, 2007). Due to the importance of iron in the human body, any
iron misregulation and abnormal iron deposition can result in neuronal death (Moos et al., 2007)
leading to neurodegenerative diseases such as MS (Abo-Krysha and Rashed, 2008). It has been
shown that there is a strong correlation between high iron concentrations (abnormal iron
presence) in the brain and neurodegeneration (Ke, 2003). In MS, iron seen in lesions come from
myelin or oligodendrocyte residues following demyelination, iron in the macrophages, or a
resultant of local microhemorrhages following microvascular wall damage. All these sources
have been strongly correlated with MS pathogenesis as mentioned earlier. On the cellular level,
new proteins (the stress protein heme oxygenase-1, for example) have been identified as key
players in iron metabolism. Although their specific role in the pathogenesis of neurodegenerative
diseases is not yet well-established (Ke, 2003), suppressing heme oxygenase-1 protein has been
shown to decrease the motor deficits seen in experimental autoimmune encephalomyelitis (EAE)
models. Free iron is known to cause the formation of highly reactive hydroxyl radicals that can
trigger cell membrane dysfunction and chronic microglial activation (Haacke et al., 2009a). It is
believed that, iron in neurodegenerative diseases accumulates through a cyclic inflammatory
process during which inflammation attracts iron-rich macrophages, leading to increases in the
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local iron content. This iron accumulation leads to further inflammation and iron deposition,
causing the system to be self-sustainable (Hammond et al., 2008).
To emphasize iron involvement in MS, several studies suggest abnormal iron deposition
in different areas of the brain, such as white matter and gray matter areas (Bakshi et al., 2000;
Haacke et al., 2009a; Hammond et al., 2008; LeVine, 1997; Neema et al., 2007). This evidence
of iron deposition has been supported by histological studies as well as by animal models such as
the EAE. Iron deposition has been typically seen in the neurons and oligodendrocytes (Celius et
al., 2000) in the thalamus and the putamen (Drayer et al., 1987) as well as in macrophages and
microglia (LeVine, 1997). To summarize, there have been indications (Brass et al., 2006; Tjoa et
al., 2005) of correlations between iron deposition, gray matter damage and clinical
manifestations of MS, providing evidence of the role of iron in the pathogenesis of MS. This has
been shown in many recent studies where they found that abnormal iron in the gray matter
structures such as the pulvinar thalamus, the thalamus and the globus pallidus correlates with
clinical outcomes, lesion load and brain atrophy (Neema et al., 2009; Zivadinov et al., 2010).
This will be more expanded in chapter 7.

5.5.2 Zinc
Many studies suggest zinc level alteration in multiple sclerosis (Cunnane et al., 1989;
Dore-Duffy et al., 1983; Ho et al., 1986). One study reported that zinc levels in erythrocytes are
significantly elevated

(three-fold higher) in patients with MS versus controls but were

dramatically decreased during clinically defined attacks (Ho et al., 1986). Zinc level increase
may be due to altered levels of cholesterol in plasma and erythrocytes in MS patients (Cunnane
et al., 1989). However, in a later study, zinc levels were reported low in the damaged areas of the
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CNS in MS (Yasui et al., 1991). These results are in agreement with what we reported in our
study (Habib et al., 2010), which is the topic of chapter 6.

5.6 Vascular involvement in MS
Recently, there has been an increased interest in a new theory that MS pathogenesis
might have both intracranial and extracranial vascular components. In a study by Zamboni et al.
in 2009 (Zamboni et al., 2009), data has shown that venous obstructions are found in MS patients
extracranially in one (or more) of the following patterns: severely stenotic jugular or vertebral
veins in the neck, a stenotic azygous vein, reduced flow in these veins, malfunctioning valves
and/or the presence of septum. These reduced flow effects lead to what has been defined as
chronic cerebrospinal venous insufficiency (CCSVI) (Zamboni et al., 2009). More recently,
several papers have shown a proclivity of MS patients exhibit these vascular abnormalities
compared to normal controls (Feng et al., 2012b). This association of extracranial venous
abnormalities with MS is thought to lead to increased stress on the venous system in the brain
and to either the development of sclerotic plaques in MS. It has also been considered to be a
source of exacerbation of the immunological cascade. However, the direct relationship between
venous obstruction, hypertension and inflammation (and hence tissue damage and lesion
development), is not yet understood. Intracranially, it has been shown that MS patients
demonstrated significant hemodynamic alterations in veins located around the lesions (Zamboni
et al., 2007). This study suggests an anatomic relationship between veins and MS inflammatory
and degenerated areas. They noted that a venous reflux was found in these areas, causing
inflammatory reaction and specifically expression of surface adhesion molecules. They
recommended that further investigations should be undertaken, since their study did not compare
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patients with and without inflammatory neurological disorders, making their conclusions nonspecific (Zamboni et al., 2007).

5.7 Neuronal Involvement in MS
Multiple sclerosis is characterized by the presence of focal demyelinated plaques in the
white matter and gray matter of the brain and the spinal cord (Lassmann, 2008). Demyelinated
lesions are seen around small veins and venules (as mentioned above) and are believed to exist as
a result of an inflammatory process. Demyelination is usually followed by a reactive astrocytic
scar formation resulting in axonal injury and loss. On the other hand, remyelination and repair
are also seen in MS lesions as newly formed thin myelin sheaths, frequently seen in new lesions.
This is a landmark which allows physicians to distinguish between MS and other diseases of
CNS. This process seems not to affect white matter only; but also global changes in the gray
matter and the normal-appearing white matter (NAWM) have been reported (Filippi et al., 1998).
The location of MS lesions in the brain and the spine is heterogeneous. However, there is more
tendency for lesions to develop the area of high vascular density (Zamboni et al., 2007) including
the periventricular and the subcortical white matter of the forebrain, the optic nerves and chiasm,
the cerebellar peduncles and the lateral columns of the spinal cord.
Active MS lesions contain many inflammatory infiltrates (T and B lymphocytes), some
plasma cells, and activated macrophages or microglial cells. The debris of the myelin sheaths or
of destroyed axons are found within the lysosomes of macrophages. Therefore, the stage of
demyelination can be estimated from the molecular composition of these degradation products
(Bruck et al., 1995). However, this is not the case in chronic inactive lesions. MR imaging is
very sensitive in detecting focal white matter lesions but cannot differentiate between partially
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demyelinated and remyelinated lesions given that they can exhibit the same cell density.
However, contrast does exist with respect to inactive lesions which show small cell density due
to the loss of oligodendrocytes (Lassmann, 2008) and NAWM (oligodendrocytes in the
remyelinated lesions may even exceed that seen in the surrounding NAWM).

5.7.1 Axonal injury and widening of the extracellular space
An important feature of MS pathology is the axonal destruction within the plaques. These
axonal injuries occur during the active stage of the lesion (Ferguson et al., 1997; Kornek et al.,
2000; Trapp et al., 1998). In active lesions, axonal density is reduced by 30%, which is due to
true axonal destruction, as well as inflammation and edema. Axonal loss is expressed much more
within permanently demyelinated lesions. During the active stage of the lesions, substantial
axonal injuries occur, while there is a further accumulation of axonal loss in demyelinated
plaques at late stages (Kornek et al., 2000). However, in both stages, axonal injury is associated
with inflammation and microglia activation (Ferguson et al., 1997; Kornek et al., 2000). Further,
there is an association between demyelination and axonal loss with a widening of the
extracellular space. This widening of the extracellular space is reported to be the result of axonal
and myelin loss as well as to edema

5.7.2 Focal white matter changes.
At the early stages of the disease, subtle changes preceding inflammation in MS plaques
are seen in white matter, which later turn into gadolinium enhanced lesions (Filippi et al., 1998).
These changes are thought to be driven by microglial activation. The detection of initial tissue
damage is possible given that multiple active lesions develop very rapidly. Afterwards, these
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abnormalities exhibits mild inflammation (through lymphocytic inflammatory infiltrates), edema,
and microglia activation (as well) in patients with progressive MS (Lassmann, 2008).

5.7.3 Diffuse changes in normal appearing white matter
Diffuse changes in NAWM are commonly seen on MR scans of patients with progressive
MS and characterized by diffuse signal abnormalities, reduction of N-acetyl aspartate, or other
quantitative MR indices. These landmarks are seen as secondary effects following axonal
destruction in focal white matter lesions (De Stefano et al., 1999; Rocca et al., 2003). These
alterations consist of some perivascular inflammatory infiltrates, small perivenous demyelinating
lesions, and diffuse astroglia and microglia activation (Allen et al., 2001) depending on the stage
of MS. For instance, in early stages, these changes represent significant diffusion of myelin
density accompanied by mild BBB damage and persistent inflammation in the brain; in patients
with primary and secondary progressive MS however, chronic perivascular and parenchymal
infiltration of the tissue with T-lymphocytes and profound microglia activation are prominent.
Therefore, white matter becomes affected globally and an inflammatory reaction within the brain
compartment drives this diffuse white matter damage.

5.7.4 White Matter Lesions Classification
MS is classified as a heterogeneous neurological disease based on its clinical course,
pathological mechanisms involved as well as its therapy outcomes. This heterogeneity was also
reported in radiological assessments, and validated in ex vivo and in vivo studies that investigated
different types of MS lesions.
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The first study examined the immunological and the neurobiological markers of 83
biopsies and autopsies from actively demyelinating lesions (Lucchinetti et al., 2000). This study
was able to classify these lesions into 4 categories. Category 1 (pattern I) revealed high activity
of T-lymphocytes and macrophages. Category 2 (pattern II) showed the same characteristics of
pattern I, in addition to the presence of IgG and complement C9neo at the site of myelin
destruction. These two patterns were mainly centered at small veins and have very well defined
edges (figure 5.1 A and B). On the other hand, the main difference between these two patterns
was the mechanism of myelin injury. Category 3 (pattern III), is similar to pattern I in terms of
activities (IgG is absent, but was mainly composed of T lymphocytes with macrophages and
activated microglia. However, these lesions were not centered by veins; instead myelin rims
were seen around inflamed veins within the demyelinated plaque (figure 5.1 C and D), with
some cases revealing Balo-like alternative myelinated and demyelinated tissue. This category is
also accompanies with oligodendrocytes dystrophy. Category 4 (pattern VI) was exclusively
found in PPMS patients and showed extensive loss of oligodendrocytes and absence of
remyelinated shadow plaques suggesting that the function of oligodendrocytes is impaired
(figure 5.1 E-H).
Another study examined the magnetic characteristics of the MS lesions using magnetic
resonance imaging (Haacke et al., 2009a). This study compared the visualization of MS lesions
using different conventional MRI techniques and SWI. While conventional MR techniques
evaluate water content in the lesions compared to their surrounding tissue (presence of edema for
instance), SWI assessed their iron content, which we have seen throughout this thesis that is
abnormally present in MS.
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Figure 5.1. A and B. Acute multiple sclerosis; pattern II; perivenous confluent pattern 2 lesion
with macrophage rim at active border. (A, myelin oligodendrocyte glycoprotein (MOG); B,
CD68). C and D. Acute MS; pattern III; demyelinating lesion with ill-defined borders. The
perivenous areas around inflamed vessels show lack of macrophage infiltration and
demyelination (arrows). (C, MOG; D, CD68) E-H. Primary progressive MS; pattern IV lesion.
Myelin antigens are similarly distributed in the lesions, and DNA fragmentation of
oligodendrocytes is seen in the periplaque white matter (H). (E, Luxol fast blue (LFB); F, MOG;
G, myelin-associated glycoprotein (MAG); H, double staining of in situ tailing (DNA
fragmentation) and cyclic nucleotide phosphodiesterase CNPase [myelin and oligodendrocytes]
(Lucchinetti et al., 2000).

This showed that some lesions were seen on both conventional and non conventional
methods, while other lesions were seen on only one of these techniques. Lesions seen on SWI
were further categorized into six different types (Haacke et al., 2009a): a) uniform dark lesions
on phase images representing uniform iron deposition; b) lesions detected on SWI magnitude
data only; c) perivenous lesions (similar to pattern I mentioned above) (figure 5.2A); d)
hypointense rim surrounding MS lesions (which might reveal iron macrophage activity – similar
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to pattern II seen above) (figure 5.2B); e) lesions with a dark central region (similar to pattern
III) (figure 5.2C); and f) gray matter lesions (which will be discussed in the next section).

Figure 5.2: Different types of MS lesions seen on SWI images (Haacke et al., 2009a).

5.7.5 Cortical and gray matter pathology
Until recently, MS was regarded as a disease affecting only the white matter. However, a
significant number of studies have shown that gray matter, and in particular the cerebral cortex,
is affected by demyelination (Lassmann, 2008). This occurs in two different ways: cortical
demyelination and diffuse neuronal loss with cortical atrophy.

5.7.6 Cortical demyelination
There are 3 different types of cortical demyelinated lesions: corticosubcortical,
perivascular, and subpial cortical lesions. Corticosubcortical lesions result from the expansion of
white matter lesions into the cortical tissue (Figure 5.3). Perivascular lesions are identified as
small intracortical scars. Subpial lesions are mainly found in patients with progressive disease
and are the most abundant in MS (Bo et al., 2003; Kidd et al., 1999). The locations of subpial
cortical lesions are mainly in cortical sulci and deeply in the outer surface of the brain. Cortical
demyelination are sometimes also seen the cerebellum and the hippocampus. The extent of
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cortical demyelination is high in patients with primary or secondary progressive MS and it
increases with disease duration. Subpial demyelination appears to be highly MS specific
(Kutzelnigg et al., 2005). Corticosubcortical lesions are the only Gd-enhanced lesions compared
to other cortical demyelinated lesions. BBB damage in the white matter parts of the lesions may
lead to protein extravasation and edema, which may also penetrate into the adjacent cortical
areas. Neuronal density is reduced in cortical lesions and in the adjacent normal-appearing cortex
(Wegner et al., 2006). In active cortical lesions, neuronal apoptosis and some dystrophic axons
are seen (Albert et al., 2007). Remyelination is frequently encountered and more pronounced in
cortical MS lesions as in white matter lesions (Albert et al., 2007).

Figure 5.3: The three types of cortical lesions (Bo et al., 2003). a) corticosubcortial lesions; b)
perivenous lesions (intracortical scars); c) subpial cortical lesions – CTX: cortex, WM: white
matter.

5.7.7 Cortical atrophy
MR imaging studies showed that cortical volume decreases with time in MS patients.
Moreover, neuronal and glial cell loss was seen in the demyelinated, but not in the normal
cortex. This neuronal loss in the cortex is thought to be directly related to inflammatory tissue
damage (Lassmann, 2008).
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5.7.8 Remyelination
Myelin repair within the lesions has been noticed in many systematic studies.
Remyelination is initiated in the early stages of lesion formation in many cases, but this newly
formed myelin may be unstable and subject to subsequent demyelination, i.e. remyelinated
lesions can be affected again by new demyelinating attacks (Prineas et al., 1993). Remyelination
may lead to complete restoration of myelin within the entire plaque. In early stages of lesional
activity, recruitment of new oligodendrocytes takes place and the formation of new thin myelin
sheaths becomes more frequent (Prineas et al., 1989). On the other hand, remyelination fails in
the later progressive stage of the disease. Extensive remyelination is seen in patients who die at
very old ages and with long-standing disease (Patani et al., 2007). Evidently, only when the
inflammatory disease process becomes inactive can remyelination become stable and permanent.

5.8 Correlational interpretations
5.8.1 Blood-brain barrier damage and inflammation
Using gadolinium (Gd) based MR techniques makes it possible to assess BBB damage in
MS to a certain extent. BBB disturbances were seen in active lesions, in inactive plaques as well
as in normal-appearing white matter with different degrees. Leakage of Gd has become a very
useful tool to determine the activity of the disease process in clinical setting and therapeutic
approaches. Gd enhancement characterizes the newly forming lesions in the brain and spinal
cord (Miller et al., 1988). This enhancement of the new forming lesions was seen to be
associated with inflammation (Bruck et al., 1997). On the other hand, in the progressive stage of
the disease, Gd-enhancing lesions are rare or absent, given that most of the lesions become
chronic, and does not correlate with inflammation.
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The relationship between BBB disturbances and inflammation is complicated
(Hochmeister et al., 2006). Massive BBB disturbances seen in classic active MS plaques is
generally associated with intravascular and perivascular inflammatory infiltrates (Hochmeister et
al., 2006; Kutzelnigg et al., 2005). Mild disturbance of the BBB, which seems to be below the
detection limit of Gd enhancement, is seen in some of the inflamed or not inflamed vessels at this
stage. Many vessels, however, show profound leakage of serum proteins and evidence for leaky
endothelial cells in the absence of inflammatory infiltrates (He et al., 2005). This has been
validated in MS by using a joint Gd - ultra small superparamagnetic particles of iron oxide
(USPIO) approach. USPIO helps visualize macrophage activity in vivo and Gd reveals any leak
in BBB. In animal studies (Dousset et al., 2006) as well as in a human subjects studies (Tourdias
et al., 2012), the authors were able to characterize the MS lesions as follows: a) lesions enhanced
with Gd and USPIO; b) lesions enhanced with Gd only; and c) lesions enhanced with USPIO
only. The authors concluded that what is seen with USPIO is unique and complementary to what
is seen with Gd and will better help to reveal myelin injury mechanisms in vivo.

5.8.2 BBB damage and active demyelination
Classic active lesions are infiltrated by macrophages that contain myelin degradation
products in different stages of digestion (Bruck et al., 1995). Active plaques have a peripheral
rim of ongoing myelin destruction that show dense inflammatory infiltrates and a broad rim of
activated macrophages. Thus, there is no correspondence between the absence of Gdenhancement on MR imaging scans and lesions that are inactive in terms of inflammation
(mentioned previously), ongoing demyelination, or tissue injury.
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The prognosis of Multiple Sclerosis
MS is characterized by a steady and stable rate of accumulation of neurologic
abnormalities that can be observed at an individual level. What differs among patients is the
individual slope of the neurologic deterioration. Several factors usually affect the prognosis. For
instance, older age at onset, dysfunction of long tract-related initial symptoms, progressive initial
course, and male gender are associated with a worse outcome, whereas the combination of
younger age at onset, optic neuritis as initial symptom, RR initial course, and female gender is
associated with a better prognosis. The initial course of MS is the most influential factor in the
prognosis. The second most important factor in prognosis is age at onset. Initial symptoms and
gender have a very small effect compared to initial course and age at onset. Abnormalities in the
baseline brain MR image have a predictive value as well. MR imaging findings are predictive for
the development of MS and T2 lesion volume and its changes at earlier time points are predictive
of later disability. For example, the rate of increase in the T2 lesion volume has been seen to be
three times higher in those who converted to SPMS than in those who remained in the RR stage
at follow-up. The search for other paraclinical factors that could be predictive of the outcome has
not been promising so far. For instance, the presence of the HLA-DR15 allele does not
significantly correlate with the course and severity of the disease (Celius et al., 2000; Runmarker
et al., 1994). Moreover, the issue of the presence of apolipoprotein E alleles is still inconclusive.
According to several large series of patients with MS, the epsilon 4 allele is associated with a
rapid accumulation of disability (Chapman et al., 2001) and an accelerated evolution of brain
MR imaging abnormalities (Fazekas et al., 2000). Currently, only MR imaging can provide
useful information for clinical evaluation.
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To conclude, the following are important findings in the prognosis of MS. First, the
predictive factors of the disability accumulation in MS are essentially the same as those that are
predictive of SPMS, which is not really surprising. Second, two phenomena seem to be
operating: a weak interplay between relapses and prognosis contrasting with a strong interplay
between age and prognosis.
In the next 3 chapters, we will focus on two of the previously mentioned aspects:
assessing the molecular component (specifically iron) using magnetic resonance imaging and Xray fluorescence and its correlation with the vascular component (by investigating a probable
vascular model of MS).
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Chapter Six
VISUALIZING IRON DEPOSITION IN MULTIPLE SCLEROSIS
CADAVER BRAINS
Introduction
For decades, multiple sclerosis (MS) has been understood as an inflammatory
demyelinating and neurodegenerative disease of the central nervous system (CNS) (Noseworthy
et al., 2000b). The risk factors for and sequence of events triggering MS are poorly understood
(Bielekova and Martin, 2004). Until recently, the focus of research into this complex disease has
been on immunological (Frohman et al., 2008; Prineas et al., 2001), neurological (Allen et al.,
2001; Filippi and Rocca, 2009; Sharma et al., 2006; van Waesberghe et al., 1999), cellular
(Connor and Menzies, 1995) and molecular (Dore-Duffy et al., 1983; Forge et al., 1998; Grant et
al., 2003; Ho et al., 1986; Stankiewicz et al., 2007; Walton and Kaufmann, 1984; Zamboni,
2006) events. A few early studies suggested that vascular anomalies may lead to MS (Adams,
1988; Fog, 1964; Schelling, 1986) and this hypothesis is now being reexamined by Zamboni and
others (Adhya et al., 2006; Ge et al., 2005; Ge et al., 2009; Inglese et al., 2007; Law et al., 2004;
Rashid et al., 2004; Singh and Zamboni, 2009; Zamboni, 2006; Zamboni et al., 2009; Zamboni et
al., 2007). Zamboni refers to the resulting vascular effects on the brain as “chronic cerebrospinal
venous insufficiency” or CCSVI (Zamboni et al., 2009) that leads to iron deposition in the vessel
walls (Zamboni, 2006), in the venous drainage system (Haacke et al., 2010b) and in and around
MS lesions (Haacke et al., 2009a). MRI studies using susceptibility weighted imaging (SWI)
have shown that many patients have iron overload in at least one of the structures of the basal
ganglia (Haacke et al., 2010b). A new extension to SWI called susceptibility mapping or SWIM
(for short) will make it possible to better quantify iron content without the phase artifacts present
in SWI. Both SWI and SWIM could be powerful tools to detect and quantify perivascular iron in
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vivo (Haacke et al., 2007). Other MR techniques have been used for iron quantification in vivo
(such as T2 and phase based-sequences) (Bakshi et al., 2002; Haacke et al., 2007; Xu et al.,
2008) and ex vivo (such as synchrotron X-ray fluorescence (Gh Popescu et al., 2009; Popescu et
al., 2009a; Popescu et al., 2009b) and histological staining (Hallgren and Sourander, 1958).
Recently, rapid-scanning X-ray fluorescence (Popescu et al., 2009a; Popescu et al., 2009b) (RSXRF) has been used to simultaneously and quantitatively map iron, copper and zinc in single
slices of whole human brain (Popescu et al., 2009b). In this study, SWI and RS-XRF were used
in parallel on the same brain slices to evaluate SWI as a tool to image iron in MS.

Materials And methods
Samples: Two formalin fixed MS cadaver brains were obtained from the Human Brain
and Spinal Fluid Resource Center (HSB), Los Angeles, CA under University of Saskatchewan
ethics approval (BioReb 06-250). We will refer to these two MS brains as MS1 and MS2. MS1
(HSB # 3816) is a coronal section from a 47 year old female who was clinically diagnosed with
multiple sclerosis and the gross and microscopic description provided in the HSB
neuropathology were consistent with chronic active MS plaque formation. The post mortem
interval for this brain was 20.7 hours. There was extensive irregular demyelinating periventricular plaque formation throughout the extent of the body of the right and the left lateral
ventricles with satellite extension into the respective corona radiata and the left basal ganglia
(figure 6.1 - upper). There was prominent macrophage activity and perivascular lymphocytic
cuffing. MS2 (HSB# 3867) (figure 6.1 – lower) is a coronal section from a 75 year old male,
diagnosed with MS who died of a heart attack. The postmortem interval for this brain was 12.9
hours. The gross neuropathology report was consistent with chronic MS plaque formation with
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mild atherosclerosis involving the basilar cerebral vasculature. Moreover, microscopic study
showed prominent decrease in oligodendrocyte density but no macrophage activity or
perivascular lymphocytic cuffing.

Magnetic Resonance Imaging: MR images were collected at the MR Research Facility,
(Wayne State University, Detroit, MI, USA) on a 3T Siemens Verio system using a gradient
echo based SWI sequence (α = 15o, TE = 20 ms, TR = 35 ms) and a T2 weighted Fluid
Attenuated Inversion Recovery (FLAIR) sequence. For SWI, images were acquired with 0.5 mm
resolution in the phase and readout directions, and 1 mm in the slice direction with a bandwidth
(BW) of 120 Hz/pixel, a field-of-view (FOV) of 256mm x 192mm and displayed on a 512 x 384
matrix. The parameters for FLAIR sequence acquisition were as follows: (α = 150 o, TE = 74 ms,
TR = 9000 ms, with 1 mm3 resolution, BW = 250 Hz/pixel and FOV of 256x192).
MR phase images were post-processed using high pass filtering with a central 64 x 64
matrix (Haacke et al., 2009b) zero-filling to create the SWI filtered phase images. These were
used as input into the SWIM algorithm to create quantitative susceptibility maps using SPIN
software (Signal Processing in NMR, Detroit, MI, USA). The background gelatin fill was
confirmed to have zero phase (2048 phase units). The SWIM post processing technique is used
to map out the susceptibility difference between structures.
Magnetic susceptibility is a quantitative measure of a material’s tendency to interact with
or distort an applied magnetic field. The volume susceptibility of iron measured in this paper is
affected by the spin status (for example Fe3+), the type of molecule, the number of iron atoms in
the molecule, the molecular weight, the concentration of molecule in the volume, tissue density
and others. In pathological cases, many factors are not known yet. Thus, the exact relationship
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between susceptibility and iron concentration varies in different structures and pathologies, and
is still under investigation. In this paper, we have included the iron concentration (µg/cm 2) as
measured by XRF.

Figure 6.1. Optical images of the two MS brains. Upper: MS1, Lower: MS2. Black arrows point
to visualized iron deposition.

X-Ray Fluorescence: RS-XRF imaging was performed at wiggler beam line 10-2 at the
Stanford Synchrotron Radiation Lightsource (SSRL). The incident beam was set at 12 keV and
was vertically collimated onto a Si (111) monochromator. The incident beam intensity was
monitored using a nitrogen-filled ion chamber upstream of a tantalum aperture. This aperture
produced a 100 μm x 100 μm spot on the sample with the approximate escape depth of 310 μm.
The samples were mounted on a set of motorized stages oriented at 45° to the incident beam to
minimize scatter, and raster scanned in the beam with a dwell time of 35 ms/point. A single
element silicon drift detector was placed at 90° to the incident beam. Energy windows were
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centered ([8.380 - 8,980] Kev for Zn and [6.210 - 6.700] Kev for Fe) to collect fluorescence
counts from the emission lines of Fe Kα1 and Kα2 emission lines averaged at a mean Kα energy
of (2E×Kα1 + E×Kα2)/3, all other biologically interesting elements, scatter and total incoming
counts. Data were normalized against incident energy (I0).
The data were quantified using XRF standard foils (Micromatters Inc.) using Sam’s
Microanalysis kit (http://ssrl.slac.stanford.edu/~swebb/smak.html) with the output units of ‘μg
Fe/cm2’

RESULTS
MS case 1: Iron, as identified by XRF (figure 6.2a) matches well visually with the SWIphase image (figure 6.2d). The maximum levels of iron from the different structures was
quantified and ranged from a low value of 2.08μg/cm2 (in white matter) to a highest
concentration of 62.56μg/cm2 next to the vein draining the caudate on the left side of the brain
(figure 6.2b).
Iron values near vessels in the globus pallidus and on the left side were about
62.56µg/cm2 (figure 6.2b). The overall amount of iron in the basal ganglia on the right side
seemed lower but this may be due to a slight difference in the section plane. However, the
thalamus on the right side has more iron than its corresponding structure in the other hemisphere.
Because myelin is rich in zinc, demyelinated regions show very low zinc. These regions
(figure 6.2e (black arrows)) correlate well with plaques visible with fluid attenuated inversion
recovery (FLAIR) (figure 6.2f (white arrows)). Iron is slightly elevated at the periphery of
several demyelinated plaques.
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MS case 2: XRF measured iron in the white matter and gray matter, specifically in the
deep gray matter structures (thalamus (figure 6.3a) and basal ganglia (figure 6.3a and b)) of this
case is similar to those in case 1 (figure 6.2a,b) ranging from 2.21 to 17.52 µg/cm2.
MS case 2 shows abundant iron in the basal ganglia that appears to be normal. Iron in the
basal ganglia in both hemispheres matches well between the XRF and SWI-phase image (figure
6.3a, c and d). We did not detect any large perivascular iron deposition similar to that seen in MS
case 1 but halos of iron and zinc decrease were seen at the periphery of and in some
demyelinated plaques (figure 6.3c, d, e and f).
Given the increased interest in CCSVI as a risk factor for MS, we sought to determine if
SWI might be an effective means to visualize iron deposits in MS brain by using a parallel
imaging strategy in which the presence of iron was independently confirmed using elementspecific XRF mapping. The advantage that SWI has is that it can be run on patients to monitor
iron content. It remains to be determined if phase as seen with SWI is in fact directly related to
iron content and not coming from other elements. SWI has also been shown to reveal MS lesions
that were not visualized with conventional T2 weighted imaging. This iron content can be either
from heme or non-heme (such as ferritin or hemosiderin) sources.

DISCUSSION
Single echo and multi-echo SWI sequences were acquired in this study. Multi-echo SWI
data were processed to calculate T2* maps which have been used to correlate with iron content
in the past. However, the T2* maps in this cadaver brain study did not appear to correlate with
iron content. This could be because of the confounding effect of local water content which
causes an increase in T2* counter-balancing the decrease in T2* caused by the presence of iron.
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Confounding effect of local water content was also seen in some but not all MS lesions detected
using FLAIR images, where high signals were visualized in corresponding high iron content
regions on XRF images.

Figure 6.2: Comparison between different acquired MRI sequences showing MS lesions, iron
and zinc deposition in MS1: a. XRF Fe map; b. Magnification of selected regions in (a), unit
µg/cm2; c. Fe susceptibility mapping; d. SWI phase; e. XRF Zn map, f. FLAIR

In summary, these preliminary results show a good correlation with iron as seen with
SWI and SWIM and that seen with RS-XRF. High iron content often correlated with low zinc
content as might be expected when there is a depletion of oligodendrocytes. Future work in this
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direction should include the creation of a one-to-one quantitative mapping of RS-XRF data with
SWIM data. This would make the in vivo use of SWI more available as a quantitative
methodology to map iron for patients with multiple sclerosis.
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Chapter Seven
ASSESSING IRON CONTENT IN THE DEEP GRAY MATTER OF MS PATIENTS
AND HEALTHY CONTROLS
Introduction
Multiple Sclerosis (MS) has been considered as both an autoimmune inflammatory
demyelinating disease (Lassmann et al., 2007) and a disease where venous involvement is
recognized as a possible biomarker or representing some specific damage to the tissue
(Schelling, 1986). Recently, the inter-relationship between venous abnormalities, obstructed flow
and a possible role for iron in tissue damage has been considered (Singh and Zamboni, 2009;
Zamboni et al., 2009).
To a large degree, but not exclusively, the imaging pathogenic landmarks of MS have
been well documented mostly in white matter (WM) (Filippi et al., 1998; Haacke et al., 2009a).
To a lesser degree, investigators have noticed abnormalities in cortical regions as well,
specifically near the gray matter (GM)/WM boundary and in gray matter as well (Haacke et al.,
2009a; Nelson et al., 2007). However, determining whether the starting point is in the GM or
WM is still unclear (Allen et al., 2001; Neema et al., 2009; Nelson et al., 2007). Currently, there
is an increased interest in studying how GM is affected (Filippi and Rocca, 2009; Haacke et al.,
2009a; Varga et al., 2009) and particularly deep GM involvement in MS where iron deposition
has been observed (Adams, 1988; Eissa et al., 2009; Haacke et al., 2009a). Brain iron
accumulation in neurodegenerative diseases, including MS, is not new and has been shown
histologically in the past (Craelius et al., 1982; Levine and Chakrabarty, 2004). In MS, its
source is likely due to myelin or oligodendrocyte debris, concentrated iron in the macrophages,
or as a product of local microhemorrhages following venule wall damage (Adams, 1988; Haacke
et al., 2009a). As the wall breaks down, free iron may escape outside the vessel. This process has
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typically been seen in the basal ganglia, neurons, oligodendrocytes, macrophages and microglia
(Haacke et al., 2009a). Generally, free iron is known to lead to the formation of highly reactive
hydroxyl radicals that can trigger cell membrane dysfunction (Gutteridge, 1992) and chronic
microglial activation (Lassmann et al., 2007). Thus, iron from any of the above mentioned
sources could lead to inflammation, and a further buildup of iron, causing the system to be selfsustainable (Hammond et al., 2008). When iron is present, the result is a hypointense signal on
T2 or T2* weighted images and a change in the phase for susceptibility weighted imaging (SWI)
(Haacke et al., 2010a; Neema et al., 2009; Zivadinov et al., 2010) which makes it possible to
quantify iron changes in vivo. Different results have been reported in studying iron involvement
in MS. The variations seen in these results have been related to many factors including the type
of MS studied, the sample size recruited and the methodologies used to assess iron deposition.
From these studies, a number of papers have now shown that there are increases in iron in the
basal ganglia and the thalamus (Haacke et al., 2010a; Hammond et al., 2008; Zivadinov et al.,
2010). In a recent study (Zivadinov et al., 2010), high iron was found in the pulvinar thalamus,
the thalamus and globus pallidus and they considered the iron measured by SWI to be a strong
indicator of disability progression, lesion volume accumulation and atrophy. Another study by
Burgetova et al (Burgetova et al., 2010) using T2 relaxometry showed that iron does increase in
the basal ganglia and the thalamus of MS patients but showed an inverse correlation with lesion
load. Zhang et al. (Zhang et al., 2010) also reported a correlation between T2 hypointensities
(representing iron deposition) and the patients' disabilities of the relapsing remitting MS group
they studied. Ceccarelli et al (Ceccarelli et al., 2010) investigated deep GM T2 hypointensity in
clinically isolated syndrome (CIS) MS patients and showed that iron related changes and
neurodegeneration can both occur in the early stages of MS. Recent work investigated the
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potential role extravasated iron might play by studying CSF ferritin levels, which is considered
an indirect measure of iron in the brain (Worthington et al., 2010). They found no difference
between the MS population and the control group. Another study (van Toorn et al., 2010) noted
that iron deficiency was reported in their MS group studied and iron supplementation was
prescribed to these people. Evidently, this treatment resulted in a partial recovery of their
symptoms. Thus, the role of iron in MS and its correlation with the clinical outcomes is still
unclear and new approaches to investigate brain iron in MS patients are still needed. In this
multidisciplinary work, we study a group of 52 MS patients using SWI, which is a powerful MR
methodology known to be sensitive to iron. We also present a new weighting scheme to evaluate
iron abnormalities and better differentiate between what is considered normal and abnormal iron
deposition.

Materials and Methods
Data Acquisition
Fifty-two (52) clinically definite MS patients were imaged (mean age: 43, standard
deviation: 11.73, range: 17 to 66 years) under four separate Internal Review Board approved
protocols. One hundred and twenty-two (122) normal subjects (mean age: 44, standard deviation:
13.49, range: 20 to 69 years) were included in this study to establish a normal range of iron
deposition in the structures of interest. The patient population studied covered 2 types of MS
including RRMS (31) and SPMS patients (21) (RRMS mean expanded disability status scale
(EDSS): 2.19, EDSS range: 1 to 5.5, mean disease duration: 8 years ; SPMS mean EDSS: 5.92,
EDSS range: 3 to 7.5, mean disease duration: 19 years). All patients and controls consented to be
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subjects in this study. A velocity compensated, 3D gradient echo sequence was used to generate
SWI images.
Site 1: Twelve (12) MS patients were recruited at the Detroit Medical Center, Detroit,
MI, USA for this study. SWI data were acquired on a 1.5T Sonata scanner (Siemens Medical
Solutions, Erlangen, Germany) equipped with an 8-channel head coil. Imaging parameters for
SWI were: repetition time (TR) = 57ms, echo time (TE) = 40ms; flip angle (FA) = 20°,
bandwidth (BW) = 80 Hz/pixel, Field of View (FOV) = 256x192 mm2 , matrix size 512x448),
with a resolution of 0.5x0.5x2mm3.
Site 2: Thirty-one (31) MS patients and 18 normal subjects were scanned on a 3T GE
Signa Excite HD 12.0 Twin Speed 8-channel scanner (General Electric, Milwaukee, WI, USA)
at the University of Buffalo, Buffalo, NY, USA. A multi-channel head and neck coil was used to
acquire the SWI data. The imaging parameters were: TR=40ms, TE=22ms, FA=12°, and
FOV=256x192mm2 (512x256 matrix with PhaseFOV = 0.75) and image resolution of
0.5x1x2mm3.
Site 3: Nine (9) MS patients were scanned using a 3T Siemens TIM Trio system
(Siemens Medical Solutions, Erlangen, Germany) at Jena University Hospital, Jena, Germany. A
12-channel receive head-matrix coil was used to acquire the SWI data. The imaging parameters
were: TR=29ms, TE=20ms; FA=15°, BW=120 Hz/pixel, FOV= 256 x 192 mm2, matrix 512x256
with FoV Phase=0.75, corresponding to an image resolution of 0.5x1x2mm3, iPAT = 2 (24
reference lines), 128 partitions.
Site 4: The SWI data of another 104 normal subjects (previously studied (Haacke et al.,
2010c)) were added to the 18 normal cases studied in site 2 to create a baseline for iron content
in the deep grey matter nuclei of healthy subjects as a function of age.
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The ability to use and compare data from different sites, acquired at different field
strengths, lies behind the concept that the phase values will remain constant if the product of
field strength to the echo time is kept constant and is otherwise independent of field strength or
system manufacturer (Haacke et al., 2009b). Thus, no matter what field strength is used,
evaluating iron content using phase images should report consistent results. To experimentally
test this concept, we recruited 36 normal controls from site 1, 2 and 3 who were scanned using
the parameters specific to each site and analyzed their data. The results were compared to the
104 normal cases from site 4 and indeed showed that these measured values (from site 1, 2 and
3) lay within the normal range deduced from site 4 data.

Data Analysis
A 64x64 (or equivalent) low spatial frequency kernel matrix was used to complex-divide
the original k-space data to create an effective high pass filtered phase image (Haacke et al.,
2009b). The resulting SWI filtered phase images were used as a means to quantify iron content.
The following seven deep gray matter structures were studied for iron content (methodology
described in previous studies (Haacke et al., 2010a; Haacke et al., 2010c; Zivadinov et al., 2010))
including: the globus pallidus (GP), the head of the caudate nucleus (CN), the putamen (PUT),
the thalamus (THA), the substantia nigra (SN), the red nucleus (RN) and the pulvinar thalamus
(PT).
Our in-house software SPIN (Signal Processing in NMR, MRI Institute for Biomedical
Research, Detroit, MI, USA) was used for the data analysis. Each structure was separated into
two regions-of-interest: the normal iron content region (RI) and the high iron content region
(RII). Since our interest was to quantify high iron content, our main focus was on RII and the
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total region (RI+RII). To achieve this quantification, we used the same process described in more
detail in Haacke et al. (Haacke et al., 2010c). To separate these two regions automatically,
thresholds were based on the data from recent papers (Haacke et al., 2007; Miao, 2008). For the
structures that were not included in these papers (pulvinar thalamus and thalamus), appropriate
thresholds were calculated by analyzing twenty normal cases with ages ranging from 20 to 39
years old. Otherwise, the thresholds were set using the mean value measured minus two times
the standard deviation (SD) across an elderly population to be on the conservative side as
outlined in Haacke et al (Haacke et al., 2007) and across the above mentioned 20 normal cases.
The boundary of each structure was drawn manually by three well trained graduate students and
the high iron content region was found automatically by using threshold values. The intra-class
correlation coefficient reliability (ICC) was evaluated by comparing the results of 5 different
subjects from 3 different observers using Statistical Package for Social Sciences (SPSS)
software. All three observers evaluated the same structure's average iron content in RII, the
normalized area and the total iron in the putamen. The ICC values for these measures were 0.71,
0.93 and 0.81, respectively. SPIN can output the statistical measures of the total structure and the
high iron content region for later analysis. Different measures have been evaluated (Haacke et
al., 2010c; Zivadinov et al., 2010): 1) the fraction of the structure that had high iron content
(percentage area), 2) the average putative iron per voxel in RII and 3) the total putative iron
content in the high iron content region. The main criterion to differentiate normal from abnormal
is that the measured iron content should lay outside the 95% prediction interval lines of the
normal population. Moreover, iron deposition measures were weighted according to their spread
around the mean values. This abnormality weighting AW (m) was achieved by substracting the
measured mean value (MV) from the estimated values of normal iron deposition of age matched

86

controls MVn (calculated from the linear regression) , then subtracting m times the estimated
standard deviation (SDn) (m=2 while considering a 95% confidence interval) and dividing the
results by SDn (equation 7.1).

AW (m) = ((MV-MVn) – mSDn)/ SDn

(7.1)

In this paper, the results will be shown for both m=2 and m = 3.

Results
The main purpose of this study was to quantify iron content in the basal ganglia and
thalamus of MS patients using phase information acquired from SWI data, and create a new
weighting scheme that allows us to better differentiate between normal and abnormal iron
deposition in MS patients compared to control subjects. Iron overload was well visualized in MS
patients in a number of regions related to the basal ganglia and thalamus. Figure 7.1 displays the
iron content visualized in an age matched control (age 39) and an MS patient (age 40) in the
basal ganglia and midbrain using SWI. Note that both have iron content in the red nucleus and
substantia nigra, however, iron overload was only seen in the MS case. High iron deposition can
be seen in the CN, GP, PUT and PT of this MS patient. In the normal subject, iron deposition in
these brain structures is much less and is evenly distributed.
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Figure 7.1. SWI filtered phase images displaying the basal ganglia and the midbrain of an agematched normal control (A, B, C) and MS patient (D, E, F) showing abnormal iron deposition in
the globus pallidus, putamen and the caudate nucleus (D); the substantia nigra and the red
nucleus of the midbrain (E); and the pulvinar thalamus (F).

Abnormal iron changes were seen upon visual examination in Figure 7.1, with the
quantified results appearing in Figure 7.2. Generally, the degree of abnormal iron accumulation
varied depending upon whether one measures total iron in RII, average iron in RII or the
normalized percentage area of RII. In Figure 7.2, we display these three measurements for the
CN and PT as an example to show the abnormal iron content of MS patients relative to normal
subjects.
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Figure 7.2. Average phase, normalized area and total phase of RII in CN and PT. Small dots
represent normal subjects. The solid line is the regression line and the outer dashed lines
represent the 95% prediction interval of the regression. Hollow squares and triangles represent
relapsing remitting MS patients and the solid squares and triangles represent secondary
progressive MS patients. The squares and triangles represent the left and right hemisphere. Many
of the MS patients have brain iron content beyond the 95% prediction intervals.
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Figure 7.3: Plots showing individual weighting of different parameters (average phase: upper
row, normalized area: middle row and the total phase: lower row) of the pulvinar thalamus (A, B,
C) and the red nucleus (D, E, F). The asterisks represent the RRMS patients, the triangles
represent the SPMS and the diamonds represent the healthy subjects. MS patients and normal
subjects with weighting higher than 1 are shown in the plots (these results correspond to m=3 for quantitative evaluation, please refer to table 7.1).

Figure 7.3 displays the individual weighting results calculated using Eq. (1) for the PT,
and RN. A clear separation between normal subjects and MS was visualized with MS patients
having iron content higher than 3 times the SD of normal subjects. Figure 7.4 displays the
subtotal weighting of the 4 structures for each measured parameter including average phase,
normalized area and total phase. The last graph, Figure 7.4d, shows the total weighting of all the
parameters of the CN, PT, RN and SN combined. The figure also demonstrates that there were
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no normal controls younger than roughly 40 years with abnormal iron content, as reflected by a
weight factor larger than 1.0.

Figure 7.4: Four plots showing the subtotal (A, B and C) weighting factors and the total
weighting factor (D) of the four structures with the weighting factor greater than 1 (these results
correspond to m=3): CN, PT, RN and SN. The asterisks represent the RRMS patients, the
triangles represent the SPMS patients and the diamonds represent the healthy subjects. For
quantitative results of these graphs, please refer to table 7.2.

The percentages of patients with abnormal iron content in both control subjects and MS
patients are shown in Tables 7.1 and 7.2. Note that in these tables, the evaluations and
calculations were done for both hemispheres thereby resulting in a total which is 2 times the
number of subjects*. In Table 7.1, individual weights (one parameter for one structure), subtotal
weights (one parameter for all the structures) and the total weights (all parameters for all the
structures) are displayed for m=2 and m=3 (higher than 2 and 3 times the SD, respectively).
Comparing normal subjects to MS patients (p<0.05), the total weights showed that 76% of all
MS patients have abnormally high iron content (higher than 2 SD) in at least one of the
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structures whereas only 27% of controls have abnormally high iron content. Similar results were
seen for subtotal and individual weights (except in the putamen). Results for subjects with iron
deposition higher than 3 SD still show still high values for MS patients.

Table 7.1: Abnormal iron deposition weighting (percentage) for normal controls (N) and MS
patients (P).
Total Weights

N
P
80.1
29.7
Subtotal Weights
N
P
N
P
N
P
RII – Average
RII – Normalized
RII –
Phase
Area
Total Phase
17.2
52.8
17.6
63.2
16.9
52.8
4.7
21.6
4.41
19.8
–
–
Individual CN
PT
1.8
29.2
4
34.9
–
–
Weights
RN
4.4
35.8
–
–
5.8
33.01
SN
3.3
23.58
4.4
35.8
–
–
GP
4.4
8.4
3.67
10.3
–
–
THA
4.04
21.7
3.67
4.7
–
–
PUT
4.77
3.77
4.41
5.6
–
–
N: Percentage of normal subjects lying above 2 standard deviations from the normal mean
(p<0.05). P: Percentage of patients lying above 2 standard deviations from the normal mean. The
dash (–): data not available.

In table 7.2, we display the total and subtotal weights calculated from CN, PT, RN and
SN iron content that again lies above 2 and 3 times higher than SD (m=2 and 3 in Eq.(1))MS
patients were divided into RR and SP and into two age ranges (≤40 and >40). We found that
27% of the normal population, 74% of RRMS patients and 79% of SPMS patients had iron
content above 2 SD from the mean while 13% of control subjects have higher than 3 SD iron
content compared to 67% of SPMS patients and 65% RRMS patients. The younger RRMS
population tends to have a higher percentage of abnormal iron deposition compared to normal
controls. for m=2 and m=3 except for subtotal weight – average phase.
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Table 7.2: Total and subtotal iron content weightings of all the four structures (CN, PT, RN and
SN) for normal controls and MS patients with iron content higher than 3 standard deviations.
RR: Relapsing Remitting MS; SP: Secondary progressive MS; TMS: Total number of MS
patients.

20-40
41-70
20-70

20-40
41-70
20-70

20-40
41-70
20-70

20-40
41-70
20-70
*

Total Weights
RR
SP
Normal
MS/TMS
MS/TMS
High/Total
24/36 (67%)
4/8 (50%)
1/112 (1%)
16/26 (62%) 24/34 (71%) 30/132 (23%)
40/62 (65%) 28/42 (67%) 31/244* (13%)
Subtotal Weights – Normalized Area
RR
SP
Normal
MS/TMS
MS/TMS
High/Total
19/36 (53%)
4/8 (50%)
0/112 (0%)
12/26 (46%) 20/34 (59%) 15/132 (11%)
31/62 (50%) 24/42 (57%) 15/244 (6%)
Subtotal Weights – Average Phase
RR
SP
Normal
MS/TMS
MS/TMS
High/Total
16/36 (44%)
6/8 (75%)
1/112 (1%)
9/36 (35%)
14/34 (41%) 13/132 (10%)
25/62(40%) 20/42 (50%) 14/244 (6%)
Subtotal Weights – Total Phase
RR
SP
Normal
MS/TMS
MS/TMS
High/Total
17/36 (47%)
1/8 (13%)
0/112 (0%)
8/26 (31%)
17/34 (50%) 14/132 (11%)
25/62 (40%) 18/42 (43%) 14/244 (6%)

Both the left and right hemispheres measurements were included in this calculation: therefore,
since the total number of normal controls is 122, including the left and right measurements
together will lead to 244 as the total count. This doubling is also applies to the MS population
studied; there is 62 values quoted for RR and 42 values for SP, yielding a total of 104.
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Discussion
The interest and association of MS with veins and iron deposition is not new (Haacke,
2011). We know that the basal ganglia from the dentate nucleus, the midbrain and up to the
thalamostriate system are all drained by the medial venous drainage system out into the straight
sinus. It is just these regions that have increased iron content as seen with SWI and with
conventional MRI (Neema et al., 2009; Singh and Zamboni, 2009). The recent work of Haacke
et al (Haacke et al., 2010a) suggests that the iron increase seen in MRI occurs at the confluence
of the small draining veins out of the structures of interest such as the putamen, globus pallidus
and caudate nucleus. Given the previous evidence that MS is a perivenular disease and that iron
builds up in the venule wall (Adams, 1988; Zamboni, 2006), it may be that these increases in
iron represent venous endothelial. However, it is still unknown whether iron deposition is a cause
or a consequence of the inflammatory demyelinating aspect in MS pathology. On the other hand,
the work by Neema et al (Neema et al., 2009) showed the presence of deep gray matter T2
hypointensities and suggested that excessive iron deposition is associated with the progression of
disease.The plots in Figure 7.3 show that SPMS and RRMS are well separated with a dominance
of RRMS for younger ages and dominance of SPMS for older ages.
MR phase information has become more frequently used to evaluate iron content as a
function of age in the human brain (Ogg et al., 1999; Xu et al., 2008). In a previous paper, we
introduced the concept of a high iron content region and normal iron content region (Haacke et
al., 2010a; Haacke et al., 2010c). This made it possible to study not only smaller increases in iron
content more confidently but also to study both the average iron content per pixel and the
normalized area of increased iron content with age which showed different and interesting results
as mentioned earlier (Haacke et al., 2010c; Zivadinov et al., 2010). This approach revealed subtle
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changes in iron content that cannot be seen with the single region approach because even large
increases in iron in a small area would be washed out when looking at iron over the whole
region. The variability shown in our results demonstrates that evaluating abnormal iron content is
not best achieved by using total iron content measurements. Rather, more information can be
obtained by evaluating the area of the high iron content region as well as the average iron content
per pixel. These two measures appear to present better quantitative indicators of iron content
abnormality. In this study, the CN, PT, RN and SN are shown to be more susceptible to
abnormal iron deposition than the other structures studied (with RN being the most susceptible
(30%) followed by the PT (27.9%) - see table 7.1). However, no significant correlation of iron
content with EDSS was found with any of the measures we did regardless of the structure
studied. This high iron content seen in the basal ganglia, the thalamus and the midbrain
structures may be consistent with the hypothesis of venous hypertension (Singh and Zamboni,
2009).

Conclusion
Abnormal iron content using the total iron weighting scheme described herein was clearly
identified in RRMS patients especially those less than 40 years of age with almost no abnormal
iron seen in the normal population. Evidently, iron in the basal ganglia (CN), thalamus (PT) and
the midbrain (RN and SN) may be a biomarker for MS. Further work in this direction would be
to compare iron content with severity of venous disease in chronic cerebrospinal venous
insufficiency.
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Chapter Eight

CEREBRAL VASCULATURE OF SWINE AS A PROBABLE MODEL FOR
NEURODEGENERATIVE DISEASE
Introduction
The use of animal models in research has provided a wealth of information about the
etiology of many diseases (Batoulis et al., 2011; Chesselet and Richter, 2011; Li et al., 2011; Liu
et al., 2012; Mao et al., 2012). In multiple sclerosis (MS), which is known to be an inflammatory,
demyelinating disease, the main etiology remains unknown (Batoulis et al., 2011; Noseworthy et
al., 2000b). Whether inflammation is the triggering factor or a consequence of the pathological
cascade is yet to be determined (Haacke et al., 2010a). The heterogeneity of MS pathological
substrates has led to developing many animal models to address different triggering factors. The
following models are mainly used: toxic agent induction of MS (Dousset et al., 1995), viral
models (Schneider, 2009) and experimental autoimmune encephalomyelitis (EAE) models
(Batoulis et al., 2011). All these models investigate the role of the immune system in MS
development; however, other aspects including: genetic predisposition, aberrant cranial anatomy,
vascular risk factors, and traumatic brain injury have shown evidence as potential causative or
progressive agents to the disease (Damadian and Chu, 2011; Haacke, 2011; Milo and Kahana,
2010; Ramagopalan et al., 2010), therefore necessitating further investigation.
Recently, the role of vascular abnormalities in MS has regained a worldwide interest as a
probable contributing factor to the pathology of MS (Zamboni et al., 2009). This study of
Zamboni et al. has shown that extracranial venous anomalies are seen in MS patients and
strongly correlate with the disease course. This has led researchers to look for a correlation of
vascular treatment using percutaneous transluminal angioplasty (PTA) with clinical outcomes
(Zamboni et al., 2011; Zivadinov et al., 2011). Using MRI, it has been shown that MS patients
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with stenotic internal jugular veins (IJV) also show reduced outflow through these vessels with
the development of collateral outflow routes and no flow related adaption in the cervical arterial
system (Feng et al., 2012a; Haacke et al., 2012c). In the 1930s, Tracey Putnam attempted to
show the critical role of venous drainage by blocking the small veins in the canine brain
(Putnam, 1935). His results showed that, for the most part, canines developed sclerotic lesions in
the presence of obstructed blood drainage from the brain. Our goal here is to evaluate the
vasculature of the Yucatan pig in an effort to prepare for a series of experiments to see if reduced
venous flow in the pig also leads to the development of sclerotic lesions. If this can be done, it
would represent a major breakthrough in the understanding of the etiology of MS. Although this
new theory has been the main drive behind this study, MS is not the only disease with a vascular
aspect (Haacke et al., 2012a) and, thus, a vascular animal model may well benefit studies on
vascular related neurological diseases as well.
The use of pigs (swine) as animal models is not novel approach (Schook et al., 2005).
The driving force for investigating swine is the fact that their neurovasculature is similar to that
in humans. Previous swine models have been used to study cardiovascular diseases (Reffelmann
et al., 2004) as well as neurological disease (Andaluz et al., 2002; Duhaime, 2006; Kornum and
Knudsen, 2011); however, no one has used these animals to study the cerebrovascular aspect of
neurological disease. In reviewing the literature, few papers have discussed the anatomy of the
pig's cerebrovasculature with a focus on the venous side (Ghoshal and Zguigal, 1986; Lavoie et
al., 2008). Reported results do not agree on how the venous vasculature drains blood from the
brain. In one study (Ghoshal and Zguigal, 1986), Ghoshal and Zguigal show that the cerebral
blood drains along four different pathways while Lavoie et al. (Lavoie et al., 2008) show that the
blood from the brain drains through only two pathways (see figure 8.1). The disagreement
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between these two studies comes from the use of different techniques to assess the veins as well
as the number of pigs used. In this paper, we used magnetic resonance imaging (MRI) to assess
the pig's cerebrovasculature in vivo in order to understand the venous anatomy of the pig and to
show the similarities between human and pig vascular anatomy.

Material and Methods
Animals
Three micro Yucatan pigs (swine) have been used in this study and were maintained in
accordance with the National Research Council’s Guide for the Care and Use of Laboratory
Animals (2010) at Wayne State University, an AAALAC-accredited institution. All procedures
were reviewed and approved by the university’s Institutional Animal Care and Use Committee.
The ages when the pigs were imaged varied between 5 and 7 months. Amongst these three pigs,
two were female and one was male. The weight of the three pigs was 21, 22 and 23 kg
respectively.

Preparation for MR scans
After the delivery of the animals, all pigs underwent a one week acclimation period. At
the time of the MR scan, all animals were sedated using 33 mg/kg IM ketamine and 0.5 mg/kg
IM midazolam and were intubated and manually ventilated. Anesthesia was maintained with
propofol (12-20 mg/kg/hr IV continuous rate infusion) throughout the duration of transportation
and the scan. During scanning, all pigs were positioned at rest on their right side with their head
facing into the bore.
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MR protocol
Although this study is vascular by nature, the protocol consisted of many MR sequences
to assess both the structural and functional anatomy of the pig. The protocol included the
following sequences: an axial 2D time-of-flight (TOF) MR venography (with saturation pulse)
and arteriovenography (with no saturation pulse) scans for the neck and head vasculature; an
axial 2D phase-contrast (PC) MR scan for flow quantification; an axial high resolution 3D TOF
MR arteriovenography of the brain; and sagittal 3D volumetric interpolated breath-hold sequence
VIBE to assess the vasculature of the brain and neck. 2D PC MRI data were collected to observe
flow in the extracranial veins of the neck in each of the three pigs at the vertebral levels of C6/C7
and C3/C4 as well as at the outer base of the cranium. Additional extracranial flow data was
collected on the male pig to provide a more comprehensive map of flow including a slice
positioned perpendicular to flow exiting the cranium, at the inner base of the cranium, and at the
C1 neck level. 2D PC MRI data were also collected on the male pig through intracranial
structures of interest: the ophthalmic sinus, dorsal sagittal sinus (DSS), straight sinus (SS), and
transverse sinus. In addition: an axial 2D T2 weighted scan; coronal T1 weighted scan; an axial
fluid attenuated inversion recovery (FLAIR) scan; and susceptibility weighted imaging (SWI)
scan were collected to assess the structural anatomy of the pig brain. Parameters for sequences
collected are presented in Table 8.1. The following scans were collected post contrast agent
injection: 3D TOF angiography, 3D VIBE and SWI. The contrast agent used was Magnevist
[Bayer, Wayne, New Jersey] and was injected with a concentration of 0.2 mL/kg [0.1 mmol/kg]).
The total scan time was one hour and 40 minutes.
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Data processing
Data were processed using Signal Processing in Nuclear MR software (SPIN, Detroit,
Michigan). This software has been used to create 3D models of the pigs’ vasculature in order to
visualize and understand the vascular system. SPIN was also used to quantify the flow in all
vessels through a manually defined cross section at different levels of the neck and head.

Results
Structural cerebral anatomy of the pig
Figure 8.2 displays the axial slices across the whole brain seen on T2 weighted imaging.
The contrast between white matter, gray matter and the ventricles is well visualized at all levels.
This contrast was also seen on the T1 weighted images shown in figure 8.3. The T1 weighted
images, that were originally acquired coronally, are displayed in figure 8.4. This figure shows:
the cerebral hemisphere; the corpus callosum; the cerebellum; the hypothalamus; the pons and
the spinal cord. These structures are seen and well defined in the human anatomy.

Swine Cerebral Venous Vasculature
The cerebral drainage system of the pig was well visualized using high resolution 3D
TOF MR arteriovenography and 3D VIBE (figure 8.5). For our purposes, the similarity between
humans and the pig brain anatomical and vascular structures is notable in the area of the
thalamostriate veins, vein of Galen, and straight sinus (figure 8.5a). Figure 8.5 highlights the
drainage of the DSS (analogous to the superior sagittal sinus), which drains the superficial veins
of the brain. The SS drains the inferior sagittal sinus as well as the central cerebral vein and the
basal vein. The SS joins the DSS at the torcular herophili, and bifurcates primarily into the
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transverse sinuses as seen in figure 8.5b. Figure 8.6 on the other hand displays cross sections of
the brain's vasculature using susceptibility weighted imaging, which is known to reveal the
venous microvasculature. Figure 8.6a shows the superficial cerebral veins while figure 8.6b and
8.6c show an axial view revealing the thalamostriate system at the level of the basal ganglia and
midbrain of the pig.

Figure 8.1: The venous drainage system of the swine reported in the literature. The solid lines
show what was reported by Ghoshal et al. 1986 and the dashed lines show what was reported by
Lavoie et al. 2008. *The author did not report any continuity of the petrosquamous sinus.
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Figure 8.2: T2 weighted images showing an axial cross section along the whole brain, revealing
good contrast between white matter, gray matter and CSF similar to that seen in humans.

Figure 8.3: T1 weighted images showing an axial cross section along the whole brain, revealing
good contrast between white matter, gray matter and CSF similar to that in humans.
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Figure 8.4:

T1 weighted images showing coronal, axial and sagittal views (left to right)

displaying different structures of the brain and the spinal cord.

Figure 8.5: A and B - 3D post contrast MRV, C - 3D VIBE. Dorsal sagittal sinus (DSS) (black
arrow); internal cerebral vein (white chevron), thalamostriate system (black chevron); straight
sinus (SS) (white arrow); cerebral superficial veins (white arrow head); transverse sinuses (black
arrow head).
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Figure 8.6: Left and middle - SWI, Right - T1 weighted images post contrast. Superficial
cerebral veins (white arrow head) and thalamostriate system (black arrow) draining through the
internal cerebral vein into the vein of Galen back to the straight sinus (arrow head) in the pig (AC) and the human (D-F).

The vasculature at neck level
Imaging the neck using axial 2D TOF MRV and 2D TOF MRA has revealed different
components of the blood supply and blood drainage to and from the brain. Figure 8.7a shows the
common carotid arteries which bifurcate into internal and external carotid arteries. The internal
carotid arteries go on to supply the brain, while the external carotid arteries supply the frontal
part of the head. Figure 8.7b, on the other hand, shows the external jugular veins which drain the
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frontal part of the head. In addition, we see the internal jugular veins which drain the cavernous
sinus back into the brachiocephalic trunk. A large venous structure (figure 8.7c) is seen which
represents a dominant drainage route from the brain, and runs parallel with the spinal cord. Many
papers have referred to it as the ventral vertebral venous plexus (VVVP) or the paraspinal venous
network (Lavoie et al., 2008). This is homologous to the epidural plexus in humans, however, in
the supine position, the dominant outflow in the human is most commonly through the IJVs and
in the upright position through the paraspinal network (Alperin et al., 2005). In humans, the
anterior condylar confluent allows for the redirection of blood flow between these vessels (San
Millan Ruiz et al., 2012), however this structure was not clearly noted in the vasculature of the
pig. Anastomoses of varying diameter were observed between the IJV, external jugular veins
(EJV), and VVVP in all three pigs.

The vasculature as a whole
Figure 8.8 displays the entire vasculature of the pig including both arteries and veins at
the brain and neck levels as visualized on 2D TOF MRV data. As mentioned previously, the DSS
drains all the superficial veins of the brain. The straight sinus, which drains the center of the
brain, joins the DSS to drain into the transverse sinuses. The transverse sinuses run bilaterally
and then bifurcate to rostral and basal branches, with the former running between the occipital
lobe and the cerebellum and the latter running dorsal to the cerebellum. The rostral branch
connects the transverse sinus to cavernous sinus, which drains into the IJV through the emissary
veins. Conversely, the basal branch drains into the basilar sinus, which then drains into the
VVVP (or known as paraspinal venous network). The IJVs then drain into the subclavian veins
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Figure 8.7: 3D projection of the 2D MRV data set. (A,D): Common carotid artery (white arrow
head); internal carotid artery (short white arrow); external carotid artery (long white arrow);
(B,E): internal jugular vein (short black and grey arrows); external jugular vein (long black and
grey arrow) and (C,F): ventral vertebral venous plexus or also known as paravertebral veins
(black and grey arrow head) in pigs (A-C) and human subject (D-F).
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Figure 8.8: Detailed anatomical description of the drainage system of the swine brain as shown
in a 3D projection of the 2D TOF MRV data set.
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back into the heart, while the VVVP travels down caudal posterior, draining the spine, and
reaching the subclavian vein into the heart.

Quantitative flow measurements of the vasculature of the head and neck
Flow measurements at the mid neck level revealed a dominance of blood draining into
the paraspinal veins compared to the internal or external jugular veins. Table 8.2 details the
quantitative flow measurements acquired at multiple levels in the head and neck for the male pig.
DSS and the SS were collected on individual flow slices which were oriented perpendicular to
the path of the vessel. The flow through the DSS was greater than the flow through the SS at a
ratio of 2.5:1 with the DSS carrying 0.28ml/s and the SS carrying 0.11ml/s of blood. Draining
from the confluence of these two sinuses, asymmetry was found in the right and left transverse
sinus. The left was the strongly favored flow pathway carrying 0.46ml/s as the right transverse
sinus was found to carry 0.02ml/s.
As detailed above, the transverse sinus can drain to the cavernous sinus. A flow slice was
also positioned through the ophthalmic sinuses connection to the cavernous sinus as they were
observed to be large structures. These structures carried greater flow than the dural sinus, with
the right ophthalmic sinus showing 0.69ml/s and the left 0.65ml/s. Combining the flow from the
transverse sinus and ophthalmic sinus, it was estimated that flow through the cavernous sinus
was approximately 1.80ml/s; however it should be noted that smaller veins which drain to the
cavernous sinus were not included. The major outflow route from the brain in the pig has been
previously thought to be through the VVVP and separately through the emissary veins leading to
the IJV. The quantitative flow measurements suggest that this is true, with the IJV carrying a
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Table 8.1: Imaging parameters for the sequences collected during MR scanning.
Abbreviations:

TOF=time of flight; PC=phase contrast; VIBE=volumetric breath-hold

examination; TR=repetition time; TE=echo time; FA=flip angle; BW=bandwidth; FOV=field of
view; TH=thickness. *Tracking F special saturation pulse was applied to acquire 2D MRV data.

Sequence

2D TOF
MRAV*

Orientation

axial

TR (ms)
TE (ms)
FA (degrees)
BW (Hz/pixel)
FOV (mm2)
Matrix Size
Resolution
(mm2)
Slice TH (mm)

23
5.02
60
217
256x256
512x512

2D PC
3D TOF
3D
2D
3D
2D T2
SWI
MR
MR`AV
VIBE
T2WI
T1WI
FLAIR
orthogonal
axial
sagittal
axial
coronal
axial
axial
to vessel
12
28
3.97
5000
1750
7000
29
5.4
5
1.43
82
2.98
129
20
15
30
25
120
9
150
15
248
181
685
222
181
296
121
256x256
256x256 349x273 128x96 256x256 128x96 256x192
448x448 1024x1024 384x300 256x192 512x512 256x192 512x384

0.5x0.5

0.6x0.6

0.25x0.25

0.9x0.9

0.5x0.5

0.5x0.5

0.5x0.5

0.5x0.5

2.5

4

0.5

0.9

2

1

2

1
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Table 8.2: Quantitative flow measurements acquired at multiple levels in the head and neck for
the male pig. Data shown reflects the flow acquired on 7 separate phase contrast MRI slices.
Vessel name

Right Sided
Flow (ml/s)

Left Sided
Flow (ml/s)

Intracranial Venous Vasculature
Dorsal sagittal sinus
0.28
Straight sinus
0.11
Total for mid-line dural sinus
0.39
Transverse sinus
0.02
0.46
Opthalmic sinus
0.67
0.65
Total flow to cavernous sinus
0.69
1.11
Extracranial Venous Vasculature as it exits the cranium
Emissary vein of internal jugular vein
0.26
0.68
Ventral vertebral plexus
0.51
0.59
External jugular vein
0.49
0.43
Anterior facial vein
0.02
0.30
Total flow exiting cranium
1.28
2.00
Extracranial Venous Vasculature at the inner base of the skull
Internal jugular vein
0.23
0.66
Ventral vertebral plexus
1.01
0.77
External jugular vein
0.53
0.57
Anterior facial vein
0.36
1.04
Total flow at the inner base of the skull
2.13
3.04
Extracranial Venous Vasculature at the outer base of the skull
Internal jugular vein
0.23
0.64
Ventral vertebral plexus
0.66
0.95
External jugular vein
1.11
0.36
Anterior facial vein
0.55
0.97
Total flow at the outer base of the skull
2.55
2.92
Extracranial Venous Vasculature at the C1 vertebral level
Internal jugular vein
0.40
1.41
Ventral vertebral plexus
0.94
1.05
External jugular vein
0.93
0.87
Anterior facial vein
0.00
0.49
Total flow at the C1 vertebral level
2.27
3.82
Extracranial Venous Vasculature at the C4 vertebral level
Internal jugular vein
0.10
1.58
Ventral vertebral plexus
1.37
1.31
External jugular vein
0.99
1.48
Total flow at the C4 vertebral level
2.46
4.37
Extracranial Venous Vasculature at the C7 vertebral level
Internal jugular vein
0.24
1.92
Ventral vertebral plexus
1.62
1.64
External jugular vein
1.28
1.30
Total flow at the C4 vertebral level
3.14
4.86

Combined
Flow (ml/s)
0.28
0.11
0.39
0.48
1.32
1.80
0.94
1.10
0.92
0.32
3.28
0.89
1.78
1.10
1.40
5.17
0.87
1.61
1.47
1.52
5.47
1.81
1.99
1.80
0.49
6.09
1.68
2.68
2.47
6.83
2.16
3.26
2.58
8.00
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Table 8.3: Comparison of the distribution of flow through the major veins of the neck for all
three pigs. Values shown are percentage of total venous flow quantified for a given level in a
given pig, therefore the percentages will add to 100 for each pig. Abbreviations: R=right sided;
L=left sided; IJV=internal jugular vein; EJV; external jugular vein; VVVP=ventral vertebral
venous plexus; AFV=anterior facial veins.
Parameter
Sex
Age
Weight

Pig 1
Male
7 months
23 kg

R-IJV
L-IJV
R-EJV
L-EJV
R-VVVP
L-VVVP
R-AFV
L-AFV

4.2
11.7
20.4
6.6
12.1
17.4
10.1
17.4

R-IJV
L-IJV
R-EJV
L-EJV
R-VVVP
L-VVVP

1.5
23.1
14.5
21.7
19.2
20.1

R-IJV
L-IJV
R-EJV
L-EJV
R-VVVP
L-VVVP

2.9
23.4
19.8
20.0
15.6
18.3

Pig 2
Pig 3
Average (St Dev)
Female
Female
5 months
6 months
21 kg
22 kg
Foramen Magnum Flow Results
11.0
5.0
6.8 (3.7)
8.5
4.4
8.2 (3.7)
12.5
19.6
17.5 (4.3)
19.1
18.8
14.8 (7.1)
13.9
14.3
13.4 (1.2)
18.9
27.2
21.2 (5.3)
5.7
4.2
6.7 (3.0)
10.5
6.5
11.4 (5.6)
C3/4 Flow Results
0.1
1.6
1.1 (0.8)
14.4
2.2
13.2 (10.5)
13.7
22.8
17.0 (5.0)
29.4
30.1
27.1 (4.7)
16.6
19.9
18.6 (1.7)
25.7
23.3
23.0 (2.8)
C6/7 Flow Results
1.3
1.6
1.9 (0.9)
16.5
2.3
14.1 (10.7)
19.9
26.4
22.0 (3.8)
25.2
29.2
24.8 (4.6)
16.5
18.7
16.9 (1.6)
20.6
21.8
20.2 (1.8)

combined 0.89ml/s and the VVVP 1.10ml/s of flow on a flow slice positioned perpendicular to
flow as it exits the cranium. Asymmetry was found in the flow between the right and left IJV
with a ratio of 2.6:1 while the flow in the VVVP had a ratio of 1.2:1 with left sided dominance.

111

A comparison of the flow through the major veins of the neck for all three pigs is shown
in Table 8.3. Flow was normalized to total venous flow quantified in order to limit bias due to
potential differences in total flow between pigs. Veins were classified as: VVVP, IJV, EJV, and
anterior facial veins (AFV). The AFV represented a diverse group of veins including those
within the superficial, ventral region as well as those surrounding the trachea and esophagus.
The EJV included were lateral vessels which appeared to drain the nose and superficial tissues.
The IJV were identified as the continuation of the emissary vein originating from the cavernous
sinus, and their close proximity to the internal and common carotid arteries were also evident.
The VVVP were identified as those vessels surrounding the dural sac and also, when observed,
smaller vessels in the paraspinal region. Some vessels were excluded due to their small size as a
definite contour was not identified.
Flow at the outer base of the cranium shows that the VVVP carried the largest portion of
total venous outflow, and in each of the three pigs a left sided dominance was observed. The
EJV and AFV carried high flow as well, carrying a combined flow of around half of the total
venous outflow quantified in each of the three pigs (50.5+/-3.6%). Flow through the IJV was
lower than the EJV or VVVP, and shows the highest variability compared to the other vessels.
The pigs show three different trends for the IJV flow: left sided, right sided and bilateral
dominance. In pig 3, the lowest IJV flow was quantified and an increase of flow through the left
VVVP was observed without a clear increase in flow through the other vessels.
Flow at the lower neck levels of C3/4 and C6/7 demonstrated the dominance of outflow
through the EJV as flow drained into these vessels from the superficial tissues and smaller veins
of the face (the AFV were not clearly observed at these levels). The flow through the left IJV had
the highest variability. In two pigs, it carried a large portion of venous outflow (23.4% and
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16.5%); however, in one of the female pigs it carried low flow (2.3%). The right IJV was found
to carry low flow in all three pigs, including pig 2 which had right sided IJV dominance at the
base of the cranium. The right and left EJV carried relatively symmetric flow compared to the
IJV with the left EJV carrying slightly more in each of the three pigs. The EJV drained between
39.8% of total venous outflow in the male pig to 55.6% in one of the female pigs. The VVVP
carried a consistently large portion of the total venous outflow in each of the three pigs. As
observed in the EJV, the right VVVP carried slightly less flow than the left.

Discussion
The main goal of this work was to visualize and understand the cerebral vasculature of
the pig brain, its drainage and whether a vascular animal model is feasible for vascular related
neurological diseases. In a previous study, Wang el al. (Wang et al., 2010) worked on
establishing a cerebral sinus thrombosis animal model, where a thrombin was injected into the
DSS of the pig. This work revealed bilateral parasagittal infarction as well as edema, the same as
seen in humans using MRI. They concluded that pigs can be used as an animal model for
cerebral sinus thrombosis to understand the associated pathophysiology and to develop better
therapeutic approaches. In another study, Chai el al. (Chai et al., 1995) designed an experiment
to test whether jugular venous ligation can change the intraluminal and intracranial pressures and
hemispheric cerebral blood flow and whether removing the ligation will reverse the effect. His
work showed that this procedure did increase cerebral blood flow but there was no increase in
jugular venous pressure or intracranial pressure. These results can be explained by the fact that
the main venous drainage system in swine is the ventral vertebral venous plexus as seen in this
paper and in Lavoie et al. (Lavoie et al., 2008). In the latter paper, the authors identified an
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anteriorly and rostrally coursing vein, named the petrosquamous sinus, which mainly drains into
the retromandibular vein. In homo sapiens, the petrosquamous sinus is an embryological remnant
structure which typically recedes during fetal development, its continued presence being linked
to increased incidence of infection and symptoms such as vertigo. Also notable was that Lavoie
et al. did not show any link between intracranial venous structures and the internal jugular veins.
This link, on the other hand, was seen in our results through the cavernous sinus which drains
into the jugular vein. Similar patterns have been described ex vivo in Ghoshal et al. (Ghoshal and
Zguigal, 1986). In addition, anastomoses have been identified in our data between the vertebral
venous plexus and the jugular veins in all three pigs, as well as anastomoses which bilaterally
link the IJV. These results suggest that the reason Chai et al. (Chai et al., 1995) failed to see any
increase in venous or intracranial pressure was because the main drainage from the brain takes
place through the vertebral venous plexus which can link back to the IJV. However, if we
occlude the ventral vertebral veins at the most cranial segment available, this might lead to the
expected increase in intracranial pressure and a form of chronic venous hypertension.
In this respect, the use of pig as a vascular model for chronic venous hypertension is
plausible. Although further research is warranted, there are still clear vascular differences
between the pig and human. The ideal effect of creating the potentially causative or exacerbating
forces generated in MS patients exhibiting chronic cerebrospinal venous insufficiency (CCSVI)
has not yet been shown; however the model template is now well understood. In pigs, drainage
of blood flow does not appear to be dominated by that from the brain as it is in the neck of
humans. Large amounts of blood flow appear to collect in the vessels from the superficial muscle
and fat pad of the pig, as well as a large supply of blood draining from the olfactory, ocular, and
gustatory tissues. This flow appears to drain primarily into the EJV and AFV, but the venous
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system of the pig is dynamic and contains connections between dominant outflow routes. Blood
flow does drain from the brain into the VVVP and to the IJV; however, this flow could
potentially become collateralized. In order to successfully obstruct blood drainage from the
brain, careful evaluation of the pig’s vasculature and precise occlusion techniques would be
needed to ensure that appropriate stress is induced in the venous system.
The results indicate that the positioning of the pig during scanning had an effect on the
overall flow in the extracranial vessels. As the pig was oriented on the right side, this may have
compressed the vessels in the neck and redirected blood flow into alternative pathways. This
may be a possible explanation for the low blood flow observed in the right IJV compared to the
left side at the lower neck levels. This type of adaption has also been evidenced in the neck of
humans, however, further research is needed to explain what effect this may have on intracranial
pressure and CCSVI.
A limitation of this study is that the quantitative flow data is not cardiac gated because of
the very rapid heart rate under sedation. Therefore, this limits the picture of whether reflux or
bidirectional flow is present in the venous system as well as obscures the ability to assess the
cerebrospinal fluid oscillatory profile. Despite this, MRI allows for the quantification of blood
flow on average, and when normalized to total arterial flow can give indications of the
redirection of blood flow in the presence of obstruction in the dominant, venous outflow routes
in comparison to the baseline explained in this work.
In conclusion, we have shown that MRI can provide a complete visualization of the
cerebral venous drainage system and its function in the pig brain and neck. Blood flow can be
quantified and the proportion of blood leaving the brain through the vertebral venous plexus and
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internal jugular vein analyzed. The structures seen suggest that in order to initiate a stress on the
venous system in the brain, the large ventral vertebral venous plexus will need to be occluded.
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Chapter Nine
CONCLUSIONS AND FUTURE DIRECTIONS
Conclusions
In this thesis, we used a modern 3T MR whole body human spectrometer to study one of
the most important molecules in the brain, iron, and its manifestation in multiple sclerosis. Due
to its magnetic characteristics, we were able to visualize and resolve the brain structures and substructures in vivo using a new technique known as susceptibility weighted imaging.

This

technique presented a better contrast and differentiation compared to conventional MR
sequences. Its accuracy was validated quantitatively against one of the most dependable iron
imaging techniques, X-Ray fluorescence, where we showed similar contrast in both methods. In
this same study where we used MS cadaver brains, we were also able to report the presence of
iron in MS lesions and other brain structures using both methodologies.
Taking it one step further, we assessed iron content in the midbrain and basal ganglia
structures in MS patients compared to normal controls. We presented a new post processing
approach to evaluate iron in the structure of interest. Our results showed an increase in iron
content in several structures of MS brains compared to healthy subjects. Specifically, we were
able to distinguish the red nucleus as being the most affected structure in older MS patients,
while increases in iron in the pulvinar thalamus was more dominant in younger subjects.
Finally, we studied the similarities between the human and the pig cerebrovascular
drainage systems and their routes to the heart through the neck vessels, as a means to create a
new animal model for MS linking iron and lesion development to vascular abnormalities. We
reported the differences, which were minor, making this model a good approach to test the
vascular theory. My major efforts in the published work of chapters 4, 6, 7 and 8 were in
designing the experiments followed by data acquisition and analysis. The next step of this project
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is underway, and we will give a brief update on the status of that study and where we are heading
as part of this work’s future direction.

Future directions:
Iron in the brain
In this thesis, we presented a new approach to assess iron content in the brain of MS
patients compared to normal subjects using phase images from SWI data. Although phase was
able to reveal abnormal iron deposition in MS patients, phase is geometry dependent. The next
step will be to repeat this analysis using a new phase post processing technique known as
susceptibility weighted imaging and mapping (SWIM) that removes this geometry dependence
and gives a magnetic source imaging measure of putative iron content. The resulting
susceptibility map has in fact been shown to correlate well with iron content using XRF and
other means. The previous phase data can be used to restudy the same group of MS patients we
originally evaluated. These SWIM data will make it possible to measure iron throughout a given
structure not just in one slice as in the previous work.

Multiple Sclerosis: a vascular model
The direct relationship between venous obstruction, iron deposition and inflammation
(and hence tissue damage and lesion development), has not been well studied, however, every
piece of this puzzle has a strong stand-alone role in MS research. A review of the literature from
the past century presents decent evidence that this new vascular theory might explain some of the
MS landmarks including immunological responses, vessel wall breakdown and iron deposition in
lesions and in the deep gray matter.
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In order to address this conflict with a convincing scientific methodology, one of the best
approaches is to develop an animal model that has similar blood drainage behavior as humans,
create vascular obstructions at different degrees to stress the cerebral venous system, and monitor
the different aspects of venous hypertension, reduced blood flow in the brain and any developing
sclerotic lesions. Changes in blood flow and iron can be monitored with MR angiography, MR
venography, quantitative flow imaging and SWI. In a clinical setting, knowing the start point is
never possible; by the time the patient has a series of symptoms, the damage has already taken
place. Therefore, the ability to visualize and monitor structural and functional changes in this
model using MRI might give us the chance to create a chronological order of the pathological
pathways seen in MS.
All the steps of this proposed direction have been independently reported in the literature,
including: similarities between the human and pig venous drainage systems (Ghoshal and
Zguigal, 1986; Si et al., 2008; Zezula-Szpyra and Grzegorzewski, 2000), the application of
venous occlusions (Schutze et al., 2007), the resulting venous hypertension in swine (Lavoie et
al., 2008) and lesion development in dogs (Putnam, 1935). Currently, we are following two
Yucatan micropigs, one with induced stenosis and the other as a companion normal control. In
our proposed implementation of this approach, the pigs were be scanned repeatedly after ligation
at post op, 3 and 6 months respectively to monitor cerebral perfusion and lesion development.
Quantitative measures will be made for vessel lumen and flow for all the major veins and arteries
feeding the brain to measure the cardiovascular input/output. Lesion load if seen will be
compared to the flow abnormalities. However, the simple presence of lesions will be considered
a major finding assuming that no lesions are present in baseline imaging. (More details of this
new direction can be found in Appendix 2.)
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In conclusion, MS is one of the most complex neurodegenerative diseases, with many
contributing factors. Any promising approach should be investigated if it has the potential to
enhance the patient’s quality of life. We hope that this work will add a piece to the MS puzzle,
whether it is through a better understanding of the role iron plays or by creating an animal model
that will lead to a better understanding of the role abnormal venous vasculature plays as a
comorbidity in multiple sclerosis.
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APPENDIX A
PHASE CONTRAST QUANTITATIVE FLOW IMAGING
Introduction
Phase contrast (PC) is an MR imaging technique that has long been used to quantify flow
parameters in vivo non-invasively. It is mainly applied to image blood and cerebrospinal fluid
flow assessing local velocity. The basic concept is the use of flow encoding gradients to translate
phase into velocity information. The application of those gradients (bipolar gradients) yields a
linear proportionality between velocity and phase, hence they are known as velocity encoding
gradients (Moran et al., 1985). In this appendix, we will briefly go through the link between
phase and velocity given that we used this method in chapter 8 to draw a map of blood flow in
the pig model.
The bipolar gradient is usually applied in the direction of the flow of interest Figure
(A.1). The gradients are applied in one of the three logical gradient axes (read encoding, phase
encoding or partition encoding direction) or can be applied along two or more if any arbitrary
direction is desired. These bipolar gradients are usually added to conventional gradient echo
sequences (Bernstein et al., 2004). However, we know from chapter 3 that there are other
contributors to the phase component in GRE sequences (such as field inhomogeneity). Therefore,
PC acquires two sets of data with the same exact parameters, except for the first moment of the
bipolar gradients. The phase images from these two data sets are subtracted on a pixel by pixel
basis, accentuating the flow while suppressing all other sources of unwanted phase information.
In doing these subtractions, two methods are commonly used and known as phase difference
(PD) and complex difference methods. Although the latter is less sensitive to partial volume
effects, the former depicts the direction of the flow and contains information about the volume
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flow rate. Given our interest with PD, we will go on to explain how it works after we introduce
the link between phase and velocity.

Figure A.1: Typical Phase contrast Pulse Sequence (Bernstein et al., 2004)

The amount of velocity encoding is manifest in the change in the gradient first moment
(Δm1). The relationship between the change in phase and Δm1 is given by:

Δφ = γΔm1ν

(A.1)

To set the dynamic range for the phase difference, the operator is asked to prescribe a parameter
known as velocity encoding (νenc), which is also known as the aliasing velocity. In other words,
νenc is defined as the velocity corresponding to a change in phase of π. From eq. A.1, we get:
γΔm1νenc = π

(A.2)
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Combining equations A.1 and A.2 yields:

Δφ = (ν/ νenc)*π

(A.3)

The choice of νenc (cm/s) depends on the amount of flow we are interested in measuring. A high
νenc gives higher dynamic range, however it reduces sensitivity to low flow. On the other hand,
low νenc gives higher sensitivity but leads aliasing when |ν| > |νenc|.
The difference in phase Δφ is calculated using the PD reconstruction method that we
mentioned earlier. This approach uses the phase information in the image domain and applies a
pixel by pixel subtraction to yield a Δφ map (Haacke, 1999). In the cases where |ν| < |νenc|, the
quantitative value of the velocity can be extracted from:

ν = (Δφ/π)* νenc

(A.4)

In the case of aliasing, however, the velocity will be underestimated and therefore, appropriate
anti-aliasing algorithms should be applied prior to PD reconstruction.
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APPENDIX B
PROGRESS TO DATE OF THE VASCULAR ANIMAL MODEL OF MS

The three pigs initially imaged to understand the cerebral venous drainage system were
considered as animal subjects to test the hypothesis. The surgery of the first pig was done and
has achieved a complete occlusion of the right vertebral vein and a partial occlusion of the left
vertebral vein (figure B.1 – post op 1 – red arrow). This process has helped decreasing the blood
drainage from the brain by 20%. In a second attempt, we were successful in occluding all the
jugular veins (internal and external) (post op 2 - red arrows). MR scans were and will be repeated
every three months to visualize any lesion development as an association between venous
abnormalities and brain damage in MS (figure B.1).
In this follow up, we have seen the development of collaterals (blue arrows) around the
occluded vessel, which is reported in the majority of patients with vascular drainage
abnormalities, giving us the confidence that we are on the right track. We aim to do quantitative
measures for vessel lumen and flow for all the major veins and arteries feeding the brain to
measure the cardiovascular input/output. Lesion load if seen will be compared to the flow
abnormalities. However, the simple presence of lesions will be considered a major finding
assuming that no lesions are present in baseline imaging.
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Figure B.1: The venous drainage system pre and post-surgery (5, 9 and 13 months follow-up).
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ABSTRACT

IMAGING IRON CONTENT IN PATIENTS WITH MULTIPLE SCLEROSIS USING
MAGNETIC RESONANCE IMAGING
by
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The importance of iron in maintaining normal physiological processes in the human body
has been well emphasized in the literature. However, "when iron behaves badly", its abnormal
presence might lead to a spectrum of pathologies depending on what function has been altered.
In the brain, for instance, abnormal iron content is thought to be associated with
neurodegenerative diseases. In this dissertation, we study iron involvement in one of the most
debilitating neurological diseases, multiple sclerosis (MS), using in vivo magnetic resonance
imaging. We first test the sensitivity and specificity of the MR method used, known as
susceptibility weighted imaging (SWI) compared to other conventional MR techniques and
rapid-scanning X-ray fluorescence in MS cadaver brains. Then, we use SWI phase images to
assess iron content in the deep gray matter structures of MS patients compared to normal
controls. Finally, we assess the possibility of developing a new MS vascular animal model to
study the link between vascular abnormalities, iron deposition and sclerotic lesions.
As a result of this work, we show that SWI provides a better contrast to image the
structures and substructures of the brain based on their iron content compared to conventional
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MR techniques. The power of SWI in imaging iron content was validated by the use of X-Ray
fluorescence (which is known to be an element specific imaging method), showing similar
contrast and making SWI the method of choice to image iron content in vivo. Using SWI, we
show a clear separation between MS patients and normal subjects, when we assessed iron
content in the midbrain, thalamus and basal ganglia. We report that out of the seven structures
studied, two were more susceptible to abnormal iron deposition (the pulvinar thalamus in young
adults, and the red nucleus in elderly people). Finally, in an MR based study, we show that the
swine and the human share a similar cerebrovascular drainage system starting from the
superficial cerebral veins and deep cervical veins all the way to the heart, aiming to use this
model to test the vascular involvement in MS.
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